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Johne’s disease (JD) in cattle is a disease of economic importance caused by 
Mycobacterium avium subspecies paratuberculosis (MAP). Studies were conducted to 
estimate the losses due to lower weaning weight of beef calves from MAP test-positive 
dams, to compare the perceptions of producers and veterinarians on the burden and 
economic aspects of MAP infection in cow-calf herds, and to evaluate whether testing 
and culling MAP test-positive cows is economically beneficial. 
Calves from cows with strong-positive ELISA results were 21.5 kg lighter at 
weaning compared to calves from ELISA-negative cows. Calves from heavy MAP 
shedding cows were 58.5 kg lighter, and calves from moderate shedders were 40.8 kg 
lighter compared to the calves from fecal-culture negative cows. Based on average 
feeder calf value during 2007 to 2012, these losses corresponded to US $57 per calf for 
ELISA strong-positive dams, US $157 per calf for heavy fecal shedder dams, and US 
$109 per calf for a moderate fecal shedder dam.  
Seedstock producers and the producers enrolled in control programs were more 
likely to have MAP uninfected herds. The average prevalence reported by producers was 
0.8%. Compared to the small herds (<50 head), the average test-positive percentages and 
estimated prevalences were reported to be higher in medium (50-149) and highest in 
large (≥150) herds. Veterinarians reported an overall animal level prevalence in their 
client herds of 5%. Seedstock herds had a lower prevalence and these producers were 
more likely to enroll in a JD control program. 
Income lost due to the presence of JD in an infected cattle herd was perceived to 
be higher by veterinarians. Compared to the veterinarians, seedstock producers were 
more likely to perceive genetic losses due to culling MAP positive cows. Average 
annual loss due to JD in a 100 cow herd with a 7% MAP prevalence was $1,644 and 
$1,747 based on information provided by producers and veterinarians, respectively. 
Herd level production decreased with increasing prevalence. Compared to test 
and cull after ELISA or ELISA followed by fecal culture, using fecal culture alone 
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provided the fastest reduction in herd prevalence. Fecal culture was also the least costly 
alternative based on long-term cumulative costs of an annual test and cull program. 
Results from the current study suggest that although testing provides faster progress, 
limiting within herd transmission by sale of all weaned calves and purchasing only low-
risk replacements can also reduce prevalence.  
Results suggest that MAP infection in cows causes significant losses for the 
calves that are produced. While the knowledge about JD varied between producers and 
veterinarians, seedstock producers were more enthusiastic about MAP control programs 
and had lower MAP prevalence in their herds. Overall losses due to MAP infection in 
the herd might be substantial. It is very costly to control or eliminate MAP once the 
infection is established in a herd. 
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Johne’s disease (JD) or paratuberculosis was first described in a German dairy 
cow (Johne and Frothingham, 1895). Mycobacterium avium subspecies paratuberculosis 
(MAP) is the etiologic agent of bovine JD, which is characterized by a chronic 
granulomatous ileocolitis, a long pre-clinical phase terminating in diarrhea, debilitation 
(Chiodini et al., 1984; Harris and Barletta, 2001), cachexia, and death (Manning and 
Collins, 2001). In infected cattle, JD is progressive with the first stage characterized by 
silent, subclinical, non-detectable infection, and the second stage with subclinical 
infection with detectable antibodies. The third appears as clinical disease showing 
normal or occasionally increased appetite and increased thirst, and the fourth stage is 
advanced clinical disease (Chiodini et al., 1984; Rossiter and Burhans, 1996; Whitlock 
and Buergelt, 1996; Radostits, 2000; Fecteau and Whitlock, 2010).  
Infected animals shed MAP into the environment increasing the risk of infection 
to susceptible calves through ingestion (Kovich et al., 2006; Pickup et al., 2006; Fecteau 
and Whitlock, 2010). Infection typically occurs due to exposure in early calfhood prior 
to weaning (Streeter et al., 1995; Benedictus et al., 2008; Windsor and Whittington, 
2010). The organism is maintained in herd through either retention of infected 
replacements or purchase of infected additions (Sweeney, 1996). Because of the chronic 
nature of the disease, transmission can occur prior to the development of clinical signs 
(Whitlock and Buergelt, 1996). Identification of infected animals for herd-level control 
is hindered because tests have low sensitivity in subclinical animals (Collins et al., 2006; 
Kudahl et al., 2007b; Kudahl et al., 2008) and identification based on clinical signs is not 
effective as the disease has a long latent period (Whitlock and Buergelt, 1996). Control 
by vaccination is restricted in some countries including the US (Stabel, 1998; Kalis et 
al., 2001; Juste, 2012) because vaccinated cattle can have false-positive test results 
hindering the testing programs for MAP (Stabel, 1998; Harris and Barletta, 2001) and 




Bovine JD is present in many regions of the world (Chiodini et al., 1984; 
Barkema et al., 2010). The overall burden is lower in beef herds compared to dairy herds 
(NAHMS, 1999; Dargatz et al., 2001; Wells et al., 2008; Good et al., 2009). It is mainly 
a disease of cattle in the US although MAP has been isolated from 19 different 
ruminants and wildlife hosts (Stevenson et al., 2009). It is less commonly reported in 
farmed deer (van Kooten et al., 2006), sheep, goats, and South American camelids 
(Stehman, 1996). It has also been reported in primates, rabbits, stoats, foxes, giraffe, 
feral cats, and birds (Manning and Collins, 2001; Corn et al., 2005; Stevenson et al., 
2009). Interspecies transmission has occurred among goats, alpaca, and farmed deer 
(Kennedy and Allworth, 2000).  
 
1.1 Johne’s disease distribution 
 It is possible that JD is present in almost all countries of the world because 
transboundary cattle export is common (Barkema et al., 2010). Underreporting is 
possible because of the long subclinical phase of JD and poor diagnostics (Chiodini et 
al., 1984; Harris and Barletta, 2001) even though it is a notifiable disease in numerous 
countries (Kennedy and Allworth, 2000; Manning and Collins, 2001). Underreporting is 
also a problem in countries that lack dedicated surveillance and reporting systems where 
the magnitude of disease might very high. Bovine JD is also a problem in the developed 
world including the USA (Whitlock, 2010), Canada (Waldner et al., 2002; Meadus et al., 
2008; Tiwari et al., 2009), France (Dufour et al., 2004), South Korea (Park et al., 2006), 
Spain (Dieguez et al., 2007), Ireland (Good et al., 2009), Denmark (Kudahl et al., 2008), 
and Australia (Manning and Collins, 2001). Sweden has an eradication program and a 
very low probability of infected herds (Frossling et al., 2012). Only one MAP-infected 
herd associated with imported animals was confirmed in 2005 (Sternberg Lewerin et al., 
2007). A systematic  review of multiple studies in Europe estimated that 50% of herds 
and 20% of cattle were infected (Nielsen and Toft, 2009).  
 The first report on bovine JD was published in 1895 by Johne and Frothingham 
(Johne and Frothingham, 1895). Prior to the discovery of MAP, a case with signs 
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consistent with JD was reported in an emaciated six year old cow with chronic extremely 
thin blackish diarrhea that contained large numbers of air-bubbles and this condition was 
described as “shooting” disease. The cow was unthrifty and emaciated but retained a 
good appetite. Gross lesions on necropsy included “corrugated” intestine with thick 
mucus. The colon and cecum were principally affected and described as having “dirty 
color with blackish streaks”(Cartwright, 1829). A subsequent report established the 
characteristics of clinical JD as a progressive wasting accompanied by a persistent 
untreatable diarrhea, emaciation, and culminating in recumbency and death. Muscle 
wasting was described as being particularly severe in the hind quarter. There were also 
thickened enteric mucosa with a wrinkled appearance, enlarged lymph nodes, and an 
enlarged, inflamed, and edematous ileocecal valve (Dunkin, 1936). 
 Dunkin (1936) reported that it was found in the UK, France, Germany, Holland, 
Italy, New Zealand, India, and South Africa. Probably the first report of JD in North 
America was by Pearson (1908), reported as a chronic bacterial dysentery of cattle 
characterized by diarrhea, normal appetite, and loss of weight eventually terminating in 
death due to extreme emaciation and exhaustion. Bang (1906) reported similar clinical 
signs and also that the feeding of enteric mucosa from affected animals could transmit 
the disease. Several studies were conducted in the 1930s to better understand the 
incubation period, methods of transmission and economic aspects (Whitlock, 2010). A 
large national survey was conducted by the National Animal Disease Center, Ames, IA. 
The prevalence in samples from 76 slaughterhouses from 32 states and Puerto Rico was 
2% during 1983-84 (Merkal et al., 1987). Subsequent to the widespread evidence of JD 
within the US, many states started JD management, control and quarantine programs 
(Chiodini et al., 1984).  
 
1.2 Johne’s disease burden in US cattle 
The overall prevalence of MAP infection is lower in beef herds compared to 
dairy herds. The NAHMS Dairy’96 study estimated that 3.4% of dairy cows were 
infected (NAHMS, 1999) compared to 0.4% beef cows being seropositive in Beef’97 
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study (NAHMS, 1999; Dargatz et al., 2001). Beef herds in a JD control program in 
Minnesota had lower (0 - 4.5%) overall seroprevalence compared to dairy herds (3.4 to 
9.9%) during 2001 through 2006 (Wells et al., 2008). Seroprevalence in samples from 
1,954 dairy cattle was 8% compared to 5% in beef herds of Missouri (Thorne and 
Hardin, 1997). Cull dairy cows from sale barns in Georgia had a seroprevalence of 10% 
compared to 4% in cull beef cows (Pence et al., 2003). Another study from 76 
slaughterhouses in 32 US states and Puerto Rico submitting ileocecal lymph nodes from 
7,540 cows estimated a prevalence of 2.9% in dairy culls compared to 0.8% in beef culls 
(Merkal et al., 1987). A survey of cattle herds with MAP shedders estimated a true 
animal-level prevalence of 8% in beef compared to 21% in dairy herds in Ireland (Good 
et al., 2009). 
There have been several published reports evaluating JD in US beef cattle 
utilizing a variety of testing and reporting methods. ELISA-based seroprevalence of JD 
in beef cattle was 5% in Missouri (Thorne and Hardin, 1997) and 9% in beef cattle in 
Alabama (Hill et al., 2003). Three percent of purebred beef cattle in Texas were 
seropositive and 7.3% of seropositive cattle were MAP culture positive (Roussel et al., 
2005). Culture of ileocecal lymph nodes from slaughterhouses across the US estimated 
0.8% prevalence in beef cows (Merkal et al., 1987), although this method is less 
sensitive compared to the culture of ileum itself (McKenna et al., 2005). Therefore, the 
reported prevalence might be an underestimate. Reported seroprevalences suggest a true 
prevalence of up to 28% based on adjustment for the sensitivity and specificity of 
currently available tests (Collins et al., 2006). 
 A study of US beef herds estimated that 8% of herds had at least one 
seropositive animal (NAHMS, 1999; Dargatz et al., 2001). Approximately 44% of 
purebred beef herds in Texas had at least one seropositive animal and 18% of 
seropositive herds had at least one animal that was MAP culture positive (Roussel et al., 
2005). Sixty-three percent of beef herds were positive in Alabama (Hill et al., 2003), and 
40% of beef herds were positive in Missouri (Thorne and Hardin, 1997). Herd 
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prevalence is also reported to be associated with herd size in the US where 40% of herds 
of more than 300 head were found to be infected (Manning and Collins, 2001).  
 
1.3 MAP transmission 
Major methods of MAP transmission in cattle as classified by Sweeney (1996) 
are: (i) prenatal transmission – including transplacental or in utero transmission, and (ii) 
postnatal transmission – including fecal shedding and transmission to young calves by 
oral ingestion through the udder, manger, feeding utensils, and sometimes from 
contaminated milk. Experimental studies to evaluate the routes of transmission were 
conducted as early as 1916. An experiment demonstrated that pathological lesions 
following oral and intravenous administration of MAP were possible, but not from 
subcutaneous administration (M'Fadyean and Sheather, 1916). MAP transmission has 
been studied extensively in dairy cattle because of a higher prevalence and greater 
economic impact (Manning and Collins, 2010).  
 
1.3.1 Prenatal transmission 
 Transplacental or in utero transmission is a particular concern in cows at advanced 
stages of infection, when bacteria are disseminated to organs including the uterus (Seitz 
et al., 1989; Sweeney, 1996). A meta-analysis and review indicated that fetal infections 
are possible in utero from clinically or sub-clinically infected cows (Whittington and 
Windsor, 2009) and farmed deer (van Kooten et al., 2006). Presence of MAP has been 
confirmed in the uterine horns of clinical JD cows (Rohde and Shulaw, 1990) as well as 
subclinically infected embryo donor cows (Bielanski et al., 2006).  
 Semen is a possible source of infection and MAP has been detected in the semen of 
an infected bull for over a year (Khol et al., 2010). MAP has also been isolated from the 
testes, epididymis, and seminal vesicles of naturally infected bulls (Ayele et al., 2004). 
Freezing semen does not reduce the viability of MAP (Richards and Thoen, 1977). A 
study with tissue samples obtained from clinical cattle demonstrated MAP mainly in 
seminal vesicles, but less frequently in prostate and bulbourethral glands. Isolated 
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organisms were subjected to similar procedures for commercial semen processing. 
Cultural growth occurred on medium inoculated with MAP in semen extender, but no 
growth was observed in samples when the semen extender contained antibiotics (Larsen 
and Kopecky, 1970).  
 Nine percent (5/58) of fetuses were infected from MAP-shedding but subclinical 
pregnant cows. Infection status was determined by fetal tissue culture and positive 
results were identified only from heavy shedding cows (Sweeney et al., 1992b). A meta-
analysis of in utero infection estimated that 9% of fetuses from subclinical cows and 
39% from clinical JD cows were infected with MAP (Whittington and Windsor, 2009). 
Both studies (Sweeney et al., 1992b; Whittington and Windsor, 2009) estimated 
significantly higher risks for fetuses from high shedders and clinical animals. Twenty-six 
percent of fetuses from cows that had positive ileocecal lymph nodes were also MAP 
tissue culture positive (Seitz et al., 1989). There is a published case report concerning 
MAP transmission via an embryo transferred to an ELISA and fecal culture negative 
cow. The cow became ELISA positive and necropsy lesions including irregular jejunal 
corrugation, thickened mucosa, and enlarged mesenteric lymph nodes were suggestive of 
JD. Acid-fact stained bacilli were isolated in radiometric culture. The offspring was 
necropsied at 24 months of age after being raised under strict hygiene. Post-mortem 
lesions included enlarged mesenteric lymph nodes, thickened enteric mucosa along with 
microscopic evidence of giant cells, activated macrophages in Peyer’s patches, and 
stained bacilli suggestive of MAP (Manning et al., 2003). However, embryo transfer is 
considered an unlikely source of transmission when embryos are washed as 
recommended by the International Embryo Transfer Society (Bielanski et al., 2006). A 
study of 14 cows did not identify MAP culture positive embryos after harvesting from 
moderate shedder cows having necropsy lesions suggestive of MAP infection (Kruip et 
al., 2003). 
Compared to calves born to seronegative dams, calves born to MAP seropositive 
dams were seven times more likely to be seropositive (Aly and Thurmond, 2005) 
presumably due to an infection acquired either congenitally or shortly after birth. 
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Offspring of cows with higher response to serum ELISA were more likely to also 
develop a higher response to ELISA (Osterstock et al., 2008). 
 
1.3.2 Postnatal transmission 
1.3.2.1 Cow-to-calf transmission 
The majority of scientific literature suggests that the fecal-oral route via MAP 
contaminated feces, colostrum, or milk is the primary mode of transmission (Clarke, 
1997). Cow-to-calf transmission within the calving area is one of the major sources of 
MAP infection (Benedictus et al., 2008). Transmission prior to weaning also occurs in 
beef herds feeding on large, round bales of hay especially on snow-covered fields. The 
accumulation of cattle and their manure in a concentrated area facilitates the 
contamination of teats and udder with manure (Fecteau and Whitlock, 2010). As beef 
calves are not normally weaned until 5-6 months of age, this is one of the important 
routes of MAP transmission 
There is age-related resistance to infection (Sweeney, 1996; Windsor and 
Whittington, 2010). Necropsy of 1-month-old, 9-month-old and 5-11-year-old animals 
experimentally exposed to MAP identified the most severe lesions in the 1-month-old 
calves (Larsen et al., 1975). Fifty-seven percent (13/23) of calves born in an infected 
herd had evidence of JD after 26 months. However, only 17% (1/6) of older calves 
introduced to the herd developed clinical signs of JD and no cattle (0/6) greater than a 
year of age when introduced into the herd developed signs over the 26 month 
observation period (Hagan, 1938). A higher susceptibility has been attributed to the first 
few hours after birth when the gut is open to macromolecules and has a less developed 
mucosal barrier (Sweeney, 1996). Momotani et al. (1988) also hypothesize that passively 
transferred maternal antibodies facilitate MAP entrance into the intestinal mucosa of 
young calves from infected dams. 
 Exposure to higher quantities of MAP also facilitates the establishment of 
infection. A review suggested 50-1000 CFU as an infective dose for dairy calves 
(Chiodini, 1996) implying that only a few milligrams of contaminated feces would be 
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sufficient to induce infection after ingestion by a young calf. A dose of 1.5 million CFU 
given orally at 21 days and again at 22 days of age induced infection in dairy calves and 
MAP was detected in the jejunum and ileum 21 days after inoculation (Sweeney et al., 
2006). Higher amounts of MAP are present in colostrum compared to milk and the 
chance of contamination is more likely in high shedding cows (Streeter et al., 1995). 
MAP contamination of colostrum (Nielsen et al., 2008), milk (Nielsen et al., 2008), and 
water or feed for neonates facilitates transmission (Kudahl et al., 2008). Feeding 
practices including the transferring of manger sweepings from cows to younger animals 
is a significant risk factor for spreading MAP (Rossiter and Burhans, 1996).  
 Contaminated manure in the environment poses a risk of infection to neonatal 
calves via oral ingestion (Chiodini, 1996; Windsor and Whittington, 2010). In an 
experiment of horizontal cow-to-calf transmission, all calves started shedding and four 
out of five calves continued shedding even after the in-contact shedding cows were 
removed (van Roermund et al., 2007). A meta-analysis did not find a difference in risk 
by removing calves 12h versus 24h after birth (Windsor and Whittington, 2010). 
However, this study also concluded that exposure to MAP at birth increases the risk of 
progressing to clinical JD.  
 While feces are the primary source of MAP, colostrum and milk of cows with 
advanced disseminated disease are also contaminated (Slana et al., 2008). Intensity of 
fecal shedding is proportional to the concentration of organisms in the colostrum 
(Streeter et al., 1995). Older infected cows in an advanced disease state are more likely 
to have offspring that also progress to JD (Benedictus et al., 2008).  
 
1.3.2.2 Calf-to-calf transmission 
Calf-to-calf transmission has been reported in an experiment conducted with 20 
animals housed individually for three years. Two out of five susceptible calves were 
infected upon being housed with fecal culture positive calves (van Roermund et al., 
2007). Transmission might still be possible in larger groups of calves housed for a 
prolonged period of time. One of the susceptible calves was infected after introduction 
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of an infected calf indicating that there is a possibility of transmission within calves 
housed together; however, the probability of transmission is low (Santema et al., 2012). 
Ten percent (25/264) of calves from test-negative dams that were not exposed to 
contaminated calving pens became infected (Benedictus et al., 2008). Although the 
specific route of transmission was not documented, intensive housing and mixing of 
calves from different production units without known disease free status appear to 
increase the exposure and, consequently, increase probability of transmission. 
 
1.3.2.3 Risk factors for transmission 
Three aspects affecting the risk of MAP transmission are: (i) the age at time of 
exposure; (ii) dose or frequency of MAP exposure (affected by stocking density); and 
(iii) prevalence of MAP within the herd (Rossiter and Burhans, 1996). One of the most 
important methods of transmission between herds is the addition of subclinically 
infected animals (Merkal, 1984; Sweeney, 1996; Fecteau and Whitlock, 2010). A 
previously uninfected herd typically becomes infected through the purchase of infected 
carrier animals, which act as a source of infection when they shed the organism (Fecteau 
and Whitlock, 2010). Purchase of replacement cattle from herds participating in a 
control program reduces the MAP risk compared to home-reared cattle (Kovich et al., 
2006). This is based on the assumption that the cattle reared in the participating herd are 
less likely to be infected with MAP based on repeated serum and fecal tests. This also 
assumes that the purchasing herd has not tested for JD. 
In Canadian dairy herds, ELISA-seropositivity was significantly associated with 
"open heifers purchased during the last 12 months" and “group housing for pre-weaned 
calves” in a multivariable model adjusted for the effects of lactation number, herd size, 
and province (Tiwari et al., 2009). In Australian beef herds, 67% of index cases were 
introduced animals; often having a direct or indirect association with dairy or dairy 
cross-breed cattle (Larsen et al., 2012). Comingling of dairy and beef breeds is an 
important risk factor for introducing JD (Tiwari et al., 2009; Larsen et al., 2012) along 
with having multiple cows per maternity pen (Tiwari et al., 2009). Water sources, using 
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dairy-type nurse cows, previous reports of clinical JD, and Bos indicus breeds are risk 
factors for seropositivity in purebred beef herds (Roussel et al., 2005). The same report 
suggested increased risk associated with the mixing of cattle, using dairy cattle as 
embryo transfer recipients, increased cattle density at calving, and collective grazing.  
Management related activities appear to affect transmission in both beef and 
dairy herds. There is a theoretical possibility of transmission due to shared farm 
equipment, boots and clothing of farmers, and other breaches in biosecurity (Fecteau and 
Whitlock, 2010). Wildlife might be responsible for transmission between herds or 
premises. Different ruminant and non-ruminant wild animals and birds have been 
implicated in the transmission of MAP to domestic stock (Manning and Collins, 2001; 
Corn et al., 2005; van Kooten et al., 2006; Stevenson et al., 2009). 
An environment contaminated with MAP increases the risk of infection to 
susceptible animals (Kovich et al., 2006; Pickup et al., 2006; Benedictus et al., 2008). 
An environment contaminated with feces in conjunctionwith young animals that suck, 
lick, and browse is a continuous source of exposure through ingestion of MAP 
contaminated feces (Chiodini, 1996). Oral exposure with feces has produced similar 
results (Sweeney et al., 1992a; Sweeney et al., 2006). 
 The soil and water in cattle aggregating areas may promote infection in animals 
and possibly humans through consumption of contaminated water (Pickup et al., 2005; 
Pickup et al., 2006). Survival of MAP in contaminated water  under normal atmospheric 
conditions was reported as early as 1944 (Lovell et al., 1944). Water could be a 
significant reservoir as MAP survive for up to 48 weeks in water or sediment in shade 
and 12 weeks in soil or manure (Whittington et al., 2005). Survival was up to 55 weeks 
in a dry and fully shaded environment, and 24 weeks on grass germinated through 
infected fecal material (Whittington et al., 2004). Freezing of MAP contaminated feces 
for three and 15 weeks did not reduce viability (Richards and Thoen, 1977) suggesting 
that MAP could survive even in very cold climates. 
MAP is resistant to heat and chemicals including chlorine and can replicate in 
protozoa (Mura et al., 2006; Whan et al., 2006). This might explain the ability to survive 
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in the environment. Runoff from grazing areas used by MAP infected sheep has 
contaminated downstream rivers in the UK (Pickup et al., 2005; Pickup et al., 2006). 
Insects and earthworms (Fischer et al., 2003) as well as wildlife are less important hosts 
(Corn et al., 2005).  
 
1.4 Laboratory diagnosis of JD 
 The diagnosis of subclinical JD in cattle is difficult because infected animals go 
through several subclinical stages that can have long durations (Whitlock and Buergelt, 
1996). Gross lesions on necropsy and histopathological examination of the ileum and 
associated mesenteric lymph nodes can be used for early diagnosis. Other than necropsy, 
there are three general approaches to diagnose MAP infection: (i) detection of a cell-
mediated response; (ii) detection of the organism (or part of it); and (iii) detection of a 
humoral (antibody) response (Manning and Collins, 2001; Barkema et al., 2010). 
Staining of fecal samples and tissue impression slides, fecal and tissue culture, and direct 
fecal PCR have been used to detect MAP organisms. Humoral immune responses can be 
measured using Agar Gel Immunodiffusion (AGID), complement fixation (CF), and 
ELISA. Cellular immunity can be assessed using delayed-type hypersensitivity 
responses by skin testing, and gamma interferon release (Manning and Collins, 2001). 
Because fecal culture itself has imperfect sensitivity, estimated sensitivity of other tests 
using fecal culture as the gold standard are likely biased (Jubb et al., 2004; McKenna et 
al., 2005). 
 
1.4.1 Serologic tests 
Antibody ELISAs are rapid, easily standardized, and relatively inexpensive 
methods suitable for whole herd screening (Kudahl et al., 2007b). Serum ELISAs are the 
most common serological tests for the diagnosis of MAP infection in cattle and other 
farm animals, but the sensitivity varies by species and is poor in wildlife (Pruvot et al., 
2013). Currently available commercial ELISAs detect antibody to MAP. Humoral 
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immune response against MAP at an early stage of MAP infection can also be detected 
using appropriate antigens such as MAP stress-associated proteins (Kawaji et al., 2012).  
Sensitivity of ELISA has been reported to be between 26% and 59% (Sockett et 
al., 1992b; Sweeney et al., 1995; Kalis et al., 2002; van Schaik et al., 2007a). An expert 
consensus reported the sensitivity of available ELISAs for serum or milk as 25 to 35% 
with a specificity between 98 and 100% (Collins et al., 2006). Different ELISA cutoffs 
will have different sensitivity and specificity and interpretation at a higher cutoff could 
be cost-effective when a higher specificity is desired (Kalis et al., 2002). Subclinical and 
light shedding cattle are usually seronegative, while high shedders are likely to be 
seropositive (Sweeney et al., 1995). The sensitivities of current ELISAs improve with 
increasing parity or lactation, stage of the disease (Kudahl et al., 2007b) and in older 
animals (Nielsen and Toft, 2006). Sensitivity of ELISA also increases with subsequent 
testing of a cohort of cattle. ELISA positivity is more common in animals over four 
years of age (Kalis et al., 2002) and also increases with the level of fecal shedding 
(Sweeney et al., 1995; Nielsen and Toft, 2006). Therefore, ELISAs are less useful for 
detecting cattle with low, moderate or intermittent MAP shedding.  
ELISA sensitivity was significantly higher for clinical cases of JD (87%) 
compared to subclinical, light-shedding cattle (15%) (Sweeney, 1996). Sensitivities of 
three types of ELISAs using tissue culture as the reference standard were 9%, 7%, and 
17% compared to 17%, 14%, and 28% using fecal culture as the gold standard 
(McKenna et al., 2005). ELISA sensitivity based on tissue culture was 12% for cows less 
than four years of age and between 20 and 30% in older cattle (Jubb et al., 2004). This 
increase in sensitivity might be related to fecal shedding as the probability of detection 
of MAP shedding increased with the age of cattle (Kalis et al., 2002). These sensitivity 
estimates for ELISAs are considerably lower than previous estimates measured against 
fecal culture as the gold standard. Fecal culture can have low sensitivity, and there is 
often a long time period prior to detectable fecal excretion in infected animals (Jubb et 
al., 2004).  
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1.4.2 Fecal culture 
Fecal culture for MAP is considered the gold standard, but the sensitivity is less 
than perfect. Therefore it is not a good gold standard for negative results (Jubb et al., 
2004; McKenna et al., 2005). Fecal culture requires a long incubation period that can be 
three months for bovine samples (Chiodini et al., 1984) and up to six months for small 
ruminants (Collins et al., 1993). Difference in the length of incubation is related to the 
MAP strain rather than host factors. One specific strain of MAP (type I/III) from cattle 
took over three months to grow on solid media (de Juan et al., 2006). Different MAP 
strains may also have different growth requirements. Herrold's egg yolk (HEY) medium 
is the most commonly used solid media (de Juan et al., 2006), but Löwenstein-Jensen 
with mycobactin is necessary for isolation of type I/III strains of MAP. 
The HEY medium was developed in 1931 but subsequently modified to promote 
growth of MAP (Whipple et al., 1991). Fecal culture of dairy cow samples using HEY 
had a sensitivity of 54% in one population (van Schaik et al., 2007a) and 38% in another 
(Whitlock et al., 2000). Another study estimated a sensitivity of 41% (Sockett et al., 
1992a). An expert consensus reports the sensitivity of fecal culture for MAP as 55 to 
65% with a specificity between 99.8 and 100% (Collins et al., 2006) although, 
specificity of fecal culture is typically considered to be 100% (Chiodini et al., 1984; 
Merkal, 1984; Sockett et al., 1992b; Whitlock et al., 2000; van Schaik et al., 2007a; 
Benedictus et al., 2008). 
Fecal culture is considered to be expensive relative to serological methods. 
Pooling feces is an approach to reduce cost, but the sensitivity depends upon shedding 
intensity (van Schaik et al., 2007b). In the developmental phase of cultural examination, 
this method was sensitive to detect 100 organisms per gram while techniques able to 
detect one organism per gram of feces have been available since 1980s (Merkal, 1984). 
Individual results will require more time once a positive pool has been identified. The 
sensitivity of diagnostic tests for JD, based on detection of MAP in fecal samples, is 
adversely affected by the long subclinical phase with or without MAP shedding (Sockett 
et al., 1992a). Targeted sampling of older animals is a viable option because the 
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sensitivity of fecal culture improves linearly from two to five years of age (Nielsen and 
Toft, 2006). Sensitivity of fecal culture might also be increased by prolonging the 
incubation period to eight weeks for slower growing strains (de Juan et al., 2006).  
Manual Mycobacteria Growth Indicator Tube (MGIT) is a medium consisting of 
liquid broth. After supplementation, it can grow a range of mycobacterial species 
(Siddiqi and Rüsch-Gerdes, 2006). The first report of liquid culture system used in M. 
paratuberculosis detection was the BACTEC 460 based on a modified 12B (radiometric) 
culture medium.  The results indicated a better sensitivity (92%) compared to 
conventional method (60) (Collins et al., 1990b). After several decades of use of liquid 
culture for MAP, non-radiometric liquid culture protocol was developed using 
fluorescent compound activated by culture isolates. Results indicated that MGIT-liquid 
culture is a robust diagnostic culture system with a potential to perform better than 
traditional HEY media (Fyock et al., 2006). Non radiometric BACTEC MGIT 960 
system was also recommended to be used with solid media to improve sensitivity 
(Cruciani et al., 2004). Performance of MGIT and radiometric BACTEC 460 culture 
systems for MAP isolation from milk were similar (Grant et al., 2003) although 
radiometric BACTEC is recommended for ovine fecal samples (Gumber and 
Whittington, 2007). 
Radiometric culture systems provide faster results with an increased sensitivity 
compared to conventional solid media. Growth is detected by the release of 14CO2 during 
metabolism of a 14C-labeled substrate. Radiometric measurements were strongly 
correlated to spectrophotometric (r = 0.962) and plate count (r = 0.992) methods for 
measuring growth of MAP (Lambrecht et al., 1988). Sensitivity of radiometric culture 
methods and conventional fecal culture in HEY was 54% and 45%, respectively (Sockett 
et al., 1992a). Radiometric methods have greater analytical sensitivity because the 
specimens are filter-concentrated (Collins et al., 1990a) and can be positive in samples 
with as few as three viable bacteria (Lambrecht et al., 1988). Another study with samples 
from sheep also found that the BACTEC 12B medium had a better sensitivity in sheep 
feces compared to conventional solid media (Whittington et al., 1999). Another study 
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also recommended BACTEC 12B for culture and identification of MAP from 
contaminated soil and pasture samples (Whittington et al., 1998). 
The differences in sensitivity estimates from studies could be due to the difficulty 
in isolating specific strains, limited number of viable bacteria in some samples, time 
between collection and culture, sample handling techniques, and possible loss of MAP 
viability during the decontamination process. 
  
1.4.3 Culture of tissue 
Even though fecal culture is considered the gold standard, culture of ileum and 
ileocecal lymph nodes is more sensitive because it can detect a wider spectrum of 
infected animals representing all stages of disease. In a study of slaughter cows, 16% 
were MAP positive by the culture of ileum and associated lymph nodes while only 4% 
were fecal culture-positive (McKenna et al., 2005). Tissue culture might have the highest 
sensitivity for detection of MAP, but biopsy of individual animals is difficult. Further, it 
is expensive relative to other available alternatives. Tissue culture has been used in 
slaughter beef and dairy culls in the US (Merkal et al., 1987).  
 
1.4.4 Polymerase chain reaction 
Polymerase chain reaction amplifies target DNA of MAP in the sample. This 
method can also provide genetic profiles for molecular epidemiological studies from 
different hosts and different geographical locations. Many of the MAP PCRs target the 
5’ end of the DNA insertion sequence IS900 (Sockett et al., 1992a; Collins et al., 1993; 
Whittington et al., 1998; Jaravata et al., 2007; Okura et al., 2011). However, presence of 
IS900-like sequences have been identified in other mycobacteria suggesting that 
isolation on solid media is necessary to confirm phenotypic characteristics (Cousins et 
al., 1999). IS900 PCR can be used for identification of MAP from soil and pasture 
samples (Whittington et al., 1998) although false positives due to Mycobacterium 
scrofulaceum or a similar organism have been reported (Cousins et al., 1999).  
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1.4.5 Intradermal test  
 In early stages of MAP infection, the microorganism elicits a cell-mediated 
response by the host that can be described as strong delayed-type IV hypersensitivity 
reactions (Stabel, 2000). The delayed type hypersensitivity reaction is the typical 
response to an intradermal injection of a small quantity of antigen with the positive 
result characterized by monocytic infiltration into the injection site within 24 to 72 
hours. This reaction involves memory T cells with involvement of both the CD4+ and 
CD8+ fractions (Black, 1999). The currently available Johnin Test employs a purified 
protein derivative (PPD) of M. avium, (e.g. Johnin OT 133-8707) (Steadham et al., 
2002). This test is able to detect MAP infections before animals become infectious 
(Kalis et al., 2003). This test is easy to conduct and inexpensive, but has limited 
reliability in some populations because there is a possibility of cross reactions leading to 
a very low specificity (Manning and Collins, 2001). Specificity of intradermal test has 
been reported to be 94% using a skin thickness increase of 4mm or more as the cut-off 
value (Kalis et al., 2003). 
 
1.4.6 Interferon gamma assay  
 Gamma interferon is a cytokine produced by sensitized lymphocytes as part of the 
cellular immune response to MAP infections. This test measures the amount of 
interferon gamma released by peripheral blood monocytes in response to stimulation 
with MAP antigens (Manning and Collins, 2001). The test is carried out with whole 
blood samples (Wood et al., 1990) and useful even in subclinically affected animals 
(Stabel, 1996; Stabel and Whitlock, 2001). The sensitivities of the gamma interferon 
assays were 72%, 93%, and 100% in detecting subclinical non-shedders, subclinical 
shedders, and clinical cows, respectively (Billman‐Jacobe et al., 2008). Specificity of 
gamma interferon test has been reported to be 94% using a new algorithm, but ranged 
from 66 to 67% using two algorithms provided by the manufacturer (Kalis et al., 2003). 
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1.4.7 Complement fixation test  
 The complement fixation test (CFT) is often required prior to international 
shipments. This test is based on detection of complement-fixing antibodies to MAP. The 
sensitivity and specificity of the CF assay are considered to be lower than ELISA 
(Sockett et al., 1992b; Collins, 1996). The CFT has a sensitivity of 38.4 and specificity 
of 99.0 (Sockett et al., 1992b), but ranged from 62-100% in different herds (Kalis et al., 
2002).  
 
1.5 Testing strategies  
 A consensus of experts (Collins et al., 2006) recommend three basic testing options 
for commercial cow-calf and seed-stock beef herds as: (i) testing whole herd by fecal 
culture for MAP; (ii) testing whole herd with ELISA and confirm positives with fecal 
culture; and (iii) target testing of “high-risk” (thin and older) animals by fecal culture.  
 A test with higher sensitivity is desired at the beginning of a control program when 
many diseased animals are expected to be identified and culled. However, available tests 
for JD have low sensitivity and this is a major issue for control programs (Collins et al., 
2006; Kudahl et al., 2007b; Kudahl et al., 2008). Lower sensitivity leads to higher 
number of false negatives allowing them to stay in the herd and infect more herdmates. 
Lower sensitivity of ELISA compared to fecal culture complicates test based JD control. 
Because of the lower sensitivity to detect even the MAP shedding cows, serological tests 
alone are not recommended especially for the herds with higher prevalence (Sockett et 
al., 1992a).  
 Cost is an important factor to consider when designing testing strategies. A 
practical control strategy for a higher prevalence herd may be to reduce the prevalence 
after several testing-cycles and improved hygiene (Collins et al., 2006; Benedictus et al., 
2008). Sampling cows at third or higher lactation improves the test sensitivity while 
reducing the cost of sampling and testing a group (Nielsen and Toft, 2006; Tavornpanich 
et al., 2006). As a high risk group, ELISA titer is expected to be higher in cows over four 
years of age (Kalis et al., 2002) in addition to fecal shedding being greater in older 
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animals (Sweeney et al., 1995; Nielsen and Toft, 2006). Older cows are more likely to be 
infectious (shedding) rather than simply infected and these animals are more important 
to identify in the herd. The main focus of control should be the removal of infectious 
animals to reduce the spread of MAP within the herd.  
Simulation studies suggest that with an estimated prevalence of 0.1% in Swedish 
herds, the probability of freedom at the end of three years was 0.63 under ongoing 
surveillance system (Frossling et al., 2012). Despite an existing surveillance system, this 
study recommended that new surveillance activities or an intensification of current 
activities are required. After implementing semi-annual fecal culture of all adult (≥2 
year) animals in a Pennsylvania dairy farm the apparent prevalence was reduced from 
60% to less than 20% during the first five years. However, the prevalence did not decline 
to zero even after 20 years of a continuous effort (Benedictus et al., 2008). Sensitivity of 
fecal culture and ELISA appears to decrease with repeated herd testing (Whitlock et al., 
2000) because heavy shedders with good ELISA responses will be culled first from the 
herds. Prevalence in offspring from test-negative dams was 10% and significantly higher 
(27%) in infected dams when a control program was implemented in a mid-sized dairy 
herd (Benedictus et al., 2008). 
Higher testing costs should also be weighed against the cost of failing to detect 
an infected animal or misclassifying and culling a non-infected animal. The most cost-
effective sampling method does not necessarily have the best sensitivity. Based on the 
priority of a production unit, a farm manager may be willing to accept the higher risk of 
culling false-positive cows and prefer a lower specificity but higher sensitivity of the test 
or vice versa. Such decisions should vary based on all applicable costs, but direct testing 
costs are typically the most important factor affecting test selection. In the initial stages 
of control programs, cost effectiveness can be increased by targeted sampling to improve 
the positive predictive value of the testing scheme. Alternatively, pooling ten fecal 
samples has been suggested for herd monitoring (van Schaik et al., 2007b), which 
reduces the cost several fold, but the sensitivity may be lower than individual culture. 
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There are limited field reports concerning MAP eradication and is likely not 
feasible unless a herd has low (< 5%) test prevalence and has an effective herd hygiene 
management program (Collins et al., 2006). This is a limitation associated with the 
sensitivity and specificity of currently available tests (Wang et al., 2006; Benedictus et 
al., 2008). Under ideal conditions, selected tests should have maximal sensitivity and the 
whole herd must be tested with positive reactors culled for several cycles of testing 
(Collins et al., 2006). A simulation model estimated that a test with more than 70% 
sensitivity is necessary to reduce the prevalence of JD to less than 1% within ten years 
(Collins and Morgan, 1992).  
 
1.6 Johne’s disease control programs in the US 
Control programs are in effect within the USA and other countries including 
Australia, Scotland, and Japan. Some countries including Australia have a mandatory 
control program (Larsen et al., 2012) and Sweden is near countrywide eradication 
(Sternberg Lewerin et al., 2007). Control programs should be designed based on the 
disease prevalence, economic losses due to the disease and whether the objective is 
control or eradication. Decision-making for the control of animal diseases should be a 
dynamic and flexible process allowing the priorities to change over time (Ge et al., 
2007). Two major components of JD control programs are: (i) preventive management 
and hygiene improvement to reduce exposure to manure, and (ii) cull or managing test-
positive animals to avoid further infections and contamination of premises (Rossiter and 
Burhans, 1996). 
 The United States Department of Agriculture (USDA) initiated regulatory 
control of JD in 1952 with a notice issued in Puerto Rico and in all continental states 
except Maine, New Hampshire, Rhode Island, Utah, and Wyoming (Carter, 2011). 
Although JD was recognized and described in the US in 1908, JD management at the 
state level started only in the 1980s (Whitlock, 2010). Initial control efforts in the US 
were small, voluntary, and of limited scope (Chiodini et al., 1984). A national JD task 
force of state and federal government, researchers, and other stakeholders of the Johne’s 
 20 
 
Committee of the United States Animal Health Association (USAHA) developed the 
first national JD certification program for cattle (Whipple, 1993). Another strategic plan 
was developed in 2001, and a recommendation to develop a new strategic plan for JD 
was made by the USAHA-JD Committee meeting in 2007 (USAHA, 2007b). The need 
for a new five year plan was proposed to the USDA-Animal and Plant Health Inspection 
Service (APHIS), Veterinary Services (VS), and the VS accepted the strategic plan 
approved by USAHA in 2008 (USAHA, 2008).  
The US Voluntary Bovine Johne's Disease Control Program (VBJDCP) was 
developed in cooperation with the National JD Working Group and the JD committee of 
the USAHA, state veterinarians and industry representatives. It was approved by the 
USDA Animal and Plant Health Inspection Service (APHIS), Veterinary Services (VS). 
The VBJDCP was administered at the individual state level and supported by industry 
and the US federal government(VBJDCP, 2002). The USDA-APHIS-VS provided 
financial support for implementation of the control program and to assist producers with 
the cost of risk assessments, management changes, and diagnostic testing (Collins et al., 
2006). The general approach of the VBJDCP was that cattle herds were to be identified 
and classified based on MAP test status. Herds were certified at different positive and 
negative categories. Subsequent annual tests with entirely negative results were evidence 
of a higher probability that the herd was free of JD. Tests were required to be conducted 
at laboratories that had passed the check tests developed by the National Veterinary 
Services Laboratories (USDA, 2002, 2005, 2010). 
The VBJDCP consisted of three elements: education, management, and herd 
classification (Carter, 2011). An important component of education was veterinarian 
certification and an Internet-based training program was maintained at the University of 
Wisconsin. The management component was implemented by veterinarians trained and 
certified to perform JD risk assessments and develop management plans. JD certified 
veterinarians must be USDA accredited and have received additional training on JD 
epidemiology, sample collection, testing, test interpretation, state and federal program 
requirements, on-farm risk assessments, and herd management plan development. A JD 
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risk assessment is a structured investigation of management practices affecting MAP 
transmission performed by appropriately trained veterinarians and approved by state JD 
coordinators. The risk assessment is performed by assigning ordinal scores based on an 
on-farm evaluation of risk factors, environment, and owner responses related to 
management practices with respect to biosecurity. A completed risk assessment with 
assigned risk scores is used to develop the herd management plan designed to reduce 
MAP transmission. The herd management plan and laboratory testing were voluntary 
components of the program. If the producer elects to test, then it is classified as a 
positive or negative herd, with an increasing probability of JD-free status if the herd is 
negative in subsequent annual tests. Probability of a herd being free of MAP infection is 
assigned classification levels and herds at Levels 3 and 4 have 98 and 99% probability of 
being free from MAP infection, respectively herds (USDA, 2002; VBJDCP, 2002). 
Further classifications ranging from Level 1 to 6 were created in 2010 (USDA, 2010). 
The National Johne's Disease Demonstration Herd Project (NJDDHP) was 
implemented in 66 dairy and 22 beef herds from 17 states (Fossler, 2007). This project 
monitored enrolled herds for a change in the prevalence of MAP infection due to 
management practices implemented to minimize transmission. The NJDDHP began in 
2003 and ended in 2010. The project was started in 2003, but final herd enrollment 
numbers were not reached until 2005. The program focused on educating producers, 
improving herd management, and testing herds (VBJDCP, 2002). This program also 
received federal funding until 2009 and the data collection for all herds ended in 
September 2010 (USAHA, 2010).  
In certain territories of Australia, infected herds are quarantined and eradication 
is undertaken whenever an infection is suspected or confirmed (Kennedy and Allworth, 
2000). Eradication is almost complete in Sweden, but there were confirmed cases in 
imported beef cattle in 2005 (Sternberg Lewerin et al., 2007). Control of JD requires 
very effective herd biosecurity management protocols and possibly the use of diagnostic 
tests to remove existing infected stock. In the US, as a biosecurity measure, the Code of 
Federal Regulations effective May 2000 restricted the interstate movement of JD 
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positive animals to prevent the dissemination of disease (USDA, 2000). National Animal 
Health Monitoring System (NAHMS) periodically conducts field studies to monitor the 
disease situation and producers’ perceptions to inform policy decisions and formulate 
control strategies (NAHMS, 1994, 1999, 2010). 
 
1.7 Herd level Johne’s disease control strategies  
 Bovine JD control programs have two key strategies for preventing spread between 
herds and preventing spread within the herd. Eradication is possible by a strong 
commitment to these strategies over a long period of time (Sykes, 2000). A certification 
of test-negative or low-risk herds was recognized as an important step forward in efforts 
to control JD in US beef herds (Sockett, 1996) and provide better marketing 
opportunities (Benjamin et al., 2009). 
 Culling only cows shedding large quantities of MAP could be effective in 
preventing MAP transmission in combination with good management (Lu et al., 2008). 
However, a limitation of this study was arbitrary assignment of the effect of good and 
poor management. Another simulation model reported that improved management can 
cause a marked decrease in herd prevalence and total costs by reducing transmission 
routes during the early stages of JD (Bennett et al., 2010).  
 Total herd depopulation, barn cleaning and disinfection along with the removal of 
fecal material has been recommended for small herds (Chiodini et al., 1984). 
Immunization against MAP infection was first studied many years ago (Sigurdsson and 
Tryggvadottir, 1949, 1950). Vaccination is restricted in the US, but used effectively in 
Latin America and Europe (Stabel, 1998; Kalis et al., 2001; Juste, 2012). Vaccination is 
beneficial from an economic perspective, but improvement in calf management is 
important for a faster reduction in disease prevalence (van Schaik et al., 1996; 
Groenendaal et al., 2002). The only approved JD vaccine in the US is a killed MAP 
product in mineral oil adjuvant and use is limited to heavily infected areas where 




Vaccination has preventive and therapeutic effects although the infection itself 
might not be prevented (Juste et al., 2009; Juste, 2012). Vaccination has been criticized 
for this insufficient protection and the possibility of false-positive test results 
complicating control programs (Stabel, 1998; Harris and Barletta, 2001; Santema et al., 
2012). Vaccination against JD is cost-effective but the export of vaccinated animals is 
prohibited (van Schaik et al., 1996; Juste et al., 2009).  
 
1.8 Economic issues 
1.8.1 Financial impact 
The losses attributed to JD in US cattle were reported to be “tremendous” in the 
absence of control measures (Meyer, 1913). However, estimation of the economic 
impact of JD in the US is complicated by lack of data and the difficulty in defining 
disease-associated losses. Despite these limitations, losses are believed to be substantial 
with an estimated annual loss of up to $1.5 billion ($1.95 when adjusted for 2013) 
(Harris and Barletta, 2001).  
The collection of field-level economic data is expensive and time consuming due 
to the long latent period of JD. There is also a slow clinical progression and lower 
sensitivity of available tests for subclinical cases. A study of JD associated economic 
losses in dairy cattle reported a decrease in milk production of 20% compared to the 
lactation two years prior to developing clinical JD (Benedictus et al., 1987). 
A net present value approach estimated $6 million ($9.32 million in 2013) loss 
and a market value approach estimated $5.7 million ($8.9 million in 2013) loss in the 
Kentucky cattle industry (Meyer and Hall, 1994). However, such results are dependent 
upon assumptions regarding cattle cost, production levels and age of disease onset. Fecal 
culture positive cows produced 1,355 kg lower milk, and were three times more likely to 
be culled (Raizman et al., 2009). Lowered milk production and replacement due to JD 
causes a loss of $100 ($138 in 2013) and it doubles to $200 ($277 in 2013) annually per 
cow when 10% or more cows are clinically affected (Ott et al., 1999). In Michigan dairy 
herds, there was a 73.5 lb decrease in mean weight of cull cows for each 10% increase in 
test prevalence leading to a loss of $1,150 ($1,590 in 2013) for a typical (136 cow) herd. 
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Further, test-positive cows had 3% higher mortality proportions compared to test-
negative cows, leading to an average annual loss between $1,607 ($2,221 in 2013) and 
$4,400 ($60,818 in 2013) in average (136 cow) herds on the basis of lost slaughter value 
and cost of replacement heifers (Johnson-Ifearulundu et al., 1999). A typical 61-cow 
Canadian dairy herd with 8 MAP seropositive cows had a mean loss of Canadian $49 
(US$51 in 2013) per cow per year due to decreased milk production, additional culling, 
mortality, and reproductive losses accounting for 9%, 46%, 16%, and 29% of the losses, 
respectively (Tiwari et al., 2008).  
Extrapolation of results from dairy herds suggests that the economic impact in 
the beef sector could be substantial. Losses in beef cattle can also be classified as direct 
(losses from infected animals’ productivity) and indirect (culling and replacement 
changing the herd demographics) (Dorshorst et al., 2006; Kudahl et al., 2007a; Tiwari et 
al., 2008). JD in beef cattle production may cause premature culling of affected animals, 
decreased milk production ultimately reducing the weaning weights of calves, reduced 
body weight of culled animals and loss of potential markets (Ott et al., 1999). Regression 
estimates of cow and calf traits on ELISA scores in a multibreed beef herd indicated that 
higher ELISA scores were associated with longer open periods, lower ability to maintain 
weight, and lower weight of calves born and weaned (Elzo et al., 2009), all of which 
may contribute to direct economic losses.  
Indirect losses due to MAP in beef herds include reduced sales, loss of valuable 
genetic material due to premature culling, loss of export markets, lowered consumer 
confidence and the cost of litigation (Roussel, 2011). Due to regulatory and ethical 
implications, it is an ethical responsibility of producers to avoid selling infected stock 
(Rossiter and Burhans, 1996). Absence of a definitive diagnosis does not protect 
producers in such a scenario (NAHMS, 1999). Owners of infected herds, veterinary 
practitioners, and regulatory personnel should be aware of the potential liability of 
selling MAP infected livestock. Liability may extend beyond the value of the infected 
animal and include all consequential damages to the buyer. An apparently healthy 
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animal from an infected herd will not protect the seller from this liability (Chiodini et al., 
1984).  
Mortality losses exceed those associated with culling alone because the salvage 
value of the animal is also lost. Other possible losses that are not easily estimable 
include loss of breeding value of purebred cattle, poor feed conversion, increased 
susceptibility to other diseases, infertility, and costs of control programs (Jones, 1988). 
However, there are also some reports from dairy cows indicating that the mean days 
open (number of days from calving to conception) were similar between MAP fecal 
culture positive and negative cows (Raizman et al., 2009), and even a higher pregnancy 
rate in MAP-infected cows has been reported (Gonda et al., 2007). These 
counterintuitive findings may have been due to confounding factors including cow-age 
and production potential.  
Beef cow-calf operations in the US are not always profitable (TAMU, 2009). 
This reflects, in part, the contribution of beef producers that choose to raise cattle for 
reasons other than as the primary source of income. Return over total costs for cow-calf 
producers in Kansas were negative for ten of the years between 1972 and 1989 (Krause, 
1992) and for 26 of the 30 years between 1979 and 2008 (Pope et al., 2011). Producers 
might be hesitant to adopt new practices due to lack of specific knowledge. Reasons for 
beef producers not adopting best management practices include unfamiliarity, non-
applicability, cost, and need for more time to adopt. Unfamiliarity and non-applicability 
were the most common reasons associated with non-adoption of management practices 
(Gillespie et al., 2007). 
 
1.8.2 Tools for economic analysis 
Animal health economics provides a framework of concepts and tools to 
optimize animal health management. Practical application of these tools includes the 
quantification of financial impacts, optimization of decisions and cost-benefit analysis 
for the control of disease in herds. Partial budgeting, cost-benefit analysis, decision 
analysis, and systems simulation are the four most common techniques for veterinary 
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decision making at the animal, herd, and national levels (Dijkhuizen et al., 1995). Such 
tools have been used since the late 1940s in agriculture, which were mostly influenced 
by ‘operational research’ or ‘management science’ as guidance to decision makers in 
industries (McCown, 2002). 
The benefits of disease control can be evaluated using partial budgeting that 
estimates financial consequences under the scenario of a control intervention 
(Dijkhuizen et al., 1995). Decision support systems are computer-based approaches that 
employ existing data and knowledge to help a decision maker develop an economically 
prudent decision or series of decisions (Power and Sharda, 2009). Decision tree models 
are a type of decision support system that can be useful for the estimation of the overall 
economic return from a control program. Decision-making for the control of livestock 
diseases should be dynamic and flexible to avoid unnecessary cost that would otherwise 
incur due to trial and error to identify the most economic decision (Ge et al., 2007). 
There are a limited number of studies evaluating economic aspects of JD control 
strategies in beef cow-calf herds. A deterministic cost-benefit model was created to 
simulate the control of MAP in UK cow-calf herds under various control measures over 
ten years (Bennett et al., 2010). Inputs were based on the opinions of stakeholders rather 
than collected field data. Most parameters were obtained from previous models for dairy 
herds (Groenendaal et al., 2002) with some adjustment based on the results from another 
model (Kudahl et al., 2007a). Calving percent, age at first calving, calving interval, calf 
growth rate, and weaning weights were assigned based on expert opinion of the authors. 
Such model inputs are often the key components influencing the results of decision 
support tools (McCown, 2002). The Bennett et al. (2010) model accounted for the effect 
of JD and control measures in terms of changing herd prevalence and the shedding states 
of animals within the herd. The model also estimated the financial costs of the disease 
and control measures. The improvement of herd hygiene reduced newborn calf 
infections, but test and cull programs were not effective at reducing prevalence or 
disease cost after ten years. Slow progress towards eradication with test and cull 
programs has been described by previous reports from dairy herds (Collins and Morgan, 
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1992; Collins et al., 2006; Benedictus et al., 2008), mostly attributable to lower 
sensitivity of available tests (Collins and Morgan, 1992; Jubb et al., 2004; Collins et al., 
2006; Wang et al., 2006; Kudahl et al., 2007b; Benedictus et al., 2008; Kudahl et al., 
2008).  Another limitation of the Bennett et al. (2010) study is the lack of data from beef 
herds to test and validate the model. 
Webb Ware et al. (2012) developed a spreadsheet simulation model for beef 
herds in Australia and results suggested that eradication is only profitable in the longer 
term when discounts on the sale of stock from infected herds are high. Control rather 
than eradication may be the preferred option for many commercial beef herds. Factors 
that affect the decision include the discounts applied to sold animals, the duration of 
trading restrictions, and the adopted strategy. Control was important in seedstock herds 
because of the restrictions imposed on the sale of cattle through current policy and 
regulations in Australia (Kennedy and Allworth, 2000; Webb Ware et al., 2012). One of 
the major strengths of the Webb Ware et al. (2012) model was the use of data collected 
from beef producer surveys, and economic data obtained by farm monitoring. Estimates 
of annual cash flow enabled comparisons between commercial and seedstock herds. 
Decision support models for the control of JD in dairy herds based on specific 
management alternatives have been developed (Collins and Morgan, 1991; Collins and 
Morgan, 1992; Dorshorst et al., 2006). Collins and Morgan (1991) developed a 
simulation model for JD control in dairy cattle evaluating alternative courses of action 
with regard to testing and culling in an infected herd. This model estimated parameters 
from the literature and used the Reed-Frost technique to predict the rate of new 
infections. Reed-Frost techniques might be efficient when the effective contact time and 
probability of contact can be derived from field studies. Testing and culling was 
profitable when there was greater than 6% prevalence and a decrease in milk production 
of greater than 6% assuming test sensitivity of 50%, test specificity of 98%, and testing 
costs of $4 per cow. This model was further refined by developing another spreadsheet 
model for dairy herds incorporating iterative sampling techniques to account for 
uncertainty (Collins and Morgan, 1992). Both models assumed annual culling of the test-
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positive animals. The refined model used age-specific culling rates and was validated 
using published data.  
A more comprehensive decision analysis model with several farm related costs 
and benefits was developed for dairy herds by Dorshorst et al. (2006). This model 
included decision paths for herd management, testing and post-test actions. The Reed-
Frost technique was used to estimate the rate of new infections within a 100 cow herd 
tested annually. Costs associated with lowered output and costs associated with new JD 
infections were calculated for herds at different intensity of control efforts. Improving 
herd hygiene management practices was beneficial and using less expensive tests was 
better than more sensitive tests. The model suggested that it was profitable to retain test-
positive cows that were in an early stage of infection. 
 
1.8.3 Economic benefit of control 
The benefit perceived by producers, potential implications associated with 
knowing herd status, and available marketing opportunities will determine whether a 
producer will implement a control program (Rossiter and Burhans, 1996). The financial 
evaluation of losses and benefits due to JD is difficult because of the chronic nature of 
the disease. In a survey of beef cattle producers in Texas and Nebraska, more than half 
admitted that they did not have enough knowledge to estimate the financial risks and 
benefits (Hall et al., 2003).  Sixty-four percent of beef producers with herds having a 
low-risk of JD (Level 4 of the US VBJDCP) perceived some form of benefit due to 
participation in the JD control program (Benjamin et al., 2009). Thirty-eight percent of 
US dairy producers perceived a financial benefit, but only 13% of producers perceived 
an increase in revenue (Groenendaal and Wolf, 2008). Another study of low-risk dairy 
herds enrolled in the VBJDCP (Level 3 and 4) perceived that it is an economically 
beneficial strategy mainly due to improved health (43% respondents), and better market 
opportunities for surplus animals (29%) (Kovich et al., 2006).  
Classification at test-negative status Level 4 in the VBJDCP led to increased 
marketing opportunities for more than one-third (13/35) of producers (Benjamin et al., 
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2009). A similar report of low-risk dairy herds (at Levels 3 and 4 of VBJDCP) estimated 
that 90% (19/21) of producers perceived a financial benefit, and 95% (20/21) reported 
that the benefit was higher than investment (Kovich et al., 2006). Classification as low-
risk will be beneficial when market discrimination favors higher prices for cows from 
low-risk herds (Sockett, 1996; Barlow and McKenzie, 2000; Kennedy and Allworth, 
2000).  
There is a difference in the perceptions of veterinarians and producers concerning 
JD and voluntary control programs (Benjamin et al., 2010). Many beef producers 
reported financial losses due to JD and those enrolled in the NJDDHP perceived an 
increase in revenue and financial benefit (Benjamin et al., 2010). However, the 
recognition of losses is complicated by the fact that only 59% of producers and 50% of 
veterinarians attribute substantial losses in beef cattle production to JD (Benjamin et al., 
2010). Two percent of US beef producers strongly agreed and 10% of them agreed that 
JD was a significant problem for the beef industry (NAHMS, 1994). Producers reported 
that brucellosis, tuberculosis and trichomoniasis were more significant infectious disease 
problems. A subsequent NAHMS study in 1997 estimated that 92% of beef producers 
were either unaware of JD or recognized the name but knew very little about the disease 
(NAHMS, 1999). This might be due to a lower prevalence of disease in beef compared 
to dairy herds (NAHMS, 1999; Wells et al., 2008). Few beef herds tested for JD (0.2%) 
and this is likely a reflection of the producers’ lack of knowledge (NAHMS, 1998). 
Another NAHMS study during 2007–08 estimated that only 11% of producers strongly 
agreed and another 27% agreed that JD is a significant problem in the US beef industry 
(NAHMS, 2010). 
Only 13% of VBJDCP enrolled beef producers reported that they observed a 
lower JD incidence on their operations that they attributed to changes made based on the 
program (Benjamin et al., 2009). There was steady increase in program participation by 
Minnesota cattle producers in the NJDDHP and over 30% of dairy producers and 2% of 
beef producers in the state were participating by the end of 2006 (Wells et al., 2008). 
There was significant within-herd seroprevalence reduction for beef herds that 
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participated in the Management Program (set of prescribed herd hygiene 
recommendations) for at least three years. However, enrollment in management and herd 
classification programs was low among beef producers compared to dairy herds.  
A lower appreciation of the economic impacts of JD in beef herds presumably 
reduces the motivation of producers to adopt a control program. Producers enrolled in 
the NJDDHP were generally positive about their experience with the control program. 
With the knowledge about the losses due to JD, 95% of dairy producers enrolled in 
NJDDHP were happy to participate and 74% of producers indicated that general herd 
health improved with adoption of the control program. However, producers that enrolled 
in the NJDDHP would be more likely to perceive benefits compared to producers in 




2. EFFECT OF POSITIVE TEST RESULTS FOR MYCOBACTERIUM AVIUM 




Johne’s disease (JD) is caused by infection with Mycobacterium avium 
subspecies paratuberculosis (MAP) in cattle and has a long pre-clinical phase that 
progresses into diarrhea, debilitation, (Chiodini et al., 1984; Harris and Barletta, 2001) 
cachexia and death (Manning and Collins, 2001). In a specific beef herd, the presence of 
MAP-specific antibody as determined by ELISA was associated with longer open 
period, reduced ability to maintain weight, and lower weight of offspring (Elzo et al., 
2009). In addition, mortalities and sale of underweight MAP-infected cows represent a 
loss of capital for beef producers and may have negative impacts on producer reputation 
and marketability of breeding stock (Roussel, 2011). All of these factors contribute to 
direct or indirect economic losses. 
The burden of JD in the beef industry has been studied in different parts of the 
US but with considerable variation in methodology. A study of US cow-calf herds from 
23 states estimated that 8% of cow-calf herds were infected (NAHMS, 1999; Dargatz et 
al., 2001) with an overall ELISA-based cow-level seroprevalence of 0.4% (Dargatz et 
al., 2001). However, serum ELISA based prevalence up to 9% has been reported for 
different US beef herds (Thorne and Hardin, 1997; Hill et al., 2003; Pence et al., 2003; 
Roussel et al., 2005).  
While general recommendations for JD control are available, the effectiveness of 
JD control measures is largely unknown. The USDA National Johne's Disease 
Demonstration Herd Project (NJDDHP) was initiated to evaluate the effectiveness of JD 
control methods to reduce disease in herds. The NJDDHP began in 2003 and ended in 
2010. Some states had demonstration projects prior to 2003, and their data were 
incorporated into the NJDDHP database in some cases, with the earliest data dating back 
to 1999. With an objective to evaluate long-term effectiveness and feasibility of 
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management for JD control on dairy and beef cattle operations, the NJDDHP progress in 
JD control by evaluating herd management practices and test results over time (USAHA, 
2007a). 
Information on JD associated losses is important because producer consensus 
regarding the need for disease control drives the success of any coordinated control or 
eradication program. The Beef 2007-08 study by the National Animal Health Monitoring 
System study estimated that only 37% of cow-calf producers from 24 states believed that 
JD is a significant problem in US beef industry (NAHMS, 2010). Despite ongoing 
educational and scientific efforts to aid in producers’ understanding of JD and its 
potential impacts, a 2009 report indicated that only 25% of beef producers perceived a 
significant benefit of participation in control or eradication programs (Benjamin et al., 
2009). 
A potential factor impacting producers’ perceptions regarding the benefits of 
participation in control and eradication programs is the lack of estimates of the direct 
economic impacts of JD in beef cattle operations. The objective of this study was to 
estimate the association between calf weaning weight and MAP test status of the dam as 
determined by serum ELISA or bacterial culture of feces. Associated monetary losses 
relative to calves born to seronegative or culture negative cattle were estimated for cow-
calf herds enrolled in the NJDDHP. 
 
2.2 Materials and methods 
2.2.1 Study design 
This study was a retrospective analysis of data collected for the NJDDHP, a 
USDA funded project to evaluate the long-term effectiveness and feasibility of 
management-related disease control for JD on dairy and beef cattle operations.  
 
2.2.2 Procedures 
Data from 22 beef herds enrolled in the NJDDHP for the period from 1999 to 
2009 were obtained. Participating herds were tested for JD on an annual basis. A flexible 
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testing strategy was employed with a goal for at least 80% of adult cattle in the herd to 
be tested annually by a combination of ELISA and bacterial culture of feces (BCF). 
Some herds used both whole herd ELISA and BCF. Random testing of a statistical 
subset of cattle was permissible for very large herds or in states in which resources were 
limited. At a minimum, all cattle (or a statistical subset) must have been tested using 
ELISA with all ELISA-positive cattle confirmed using BCF. Testing was required to be 
performed at accredited laboratories that had passed the National Veterinary Services 
Laboratories’ JD proficiency test (USDA, 2002, 2005, 2010). Different ELISA (Table 1) 
and BCF (Table 2) tests were employed and varied by location. 
 
 
Table 1: Classification of serum-ELISA results for samples obtained from beef 
cows in participating herds 
ELISA type 
ELISA result S/P ratio cutoff 
Strong-positive Positive Suspect Negative 
ELISA 1a* >0.99 0.25-0.99 0.10-0.24 <0.10 
ELISA 2b† >3.49 1.00-3.49 0.50-0.99 <0.50 
*  Used for the samples from FL herds 
† Used for the samples from ND herd 
a HerdChek M. pt. Antibody Test Kit, IDEXX Laboratories Inc., Westbrook, ME.  








Heavy Moderate Low Very low 
BCF 1a* >50 cfu / tube 6-50 cfu / tube 1-5 cfu / tube N/A 
BCF 2b† 
<21 days to 
positive 
22-28 days to 
positive 
29-35 days to 
positive 
36-42 days to 
positive 
* Used for the samples from FL herds 
† Used for the samples from ND herd 
c Herrold’s Egg Yolk Medium, Becton Dickinson & Co, Sparks, MD.  
d ESP® Culture System II, Trek Diagnostic Systems Inc., Cleveland, OH.  
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2.2.3 Statistical analysis 
Weaning weights were adjusted to a standard of 205 days (AWW) by dividing the 
observed weaning weight by age of calf at weaning and multiplying by 205. Multilevel 
mixed effects models were used to estimate associations including random effects to 
account for repeated tests within individual cows and cows nested within herds. Models 
were fit using the lme4 package (Bates and Maechler, 2011) for statistical freeware R 
(The R Project http://sourceforge.net) and results were interpreted at the 5% level of 
significance. The association between test result (positive or negative) and AWW was 
evaluated independently for serum ELISA and BCF. Expert opinion suggests that these 
tests at evaluated cutoffs have sensitivities of 0.30 and 0.60 and specificities of 0.99 and 
one for ELISA and BCF respectively (Collins et al., 2006). The AWW served as the 
outcome of interest and test results for the dam in the year of birth for the corresponding 
calf were modeled as a fixed effect. Separate models were developed evaluating serum 
ELISA results as a dichotomy (i.e., positive or negative) and as a categorical variable 
based on interpretation guidelines (i.e., negative, suspect, positive, or strong-positive). 
Similarly, BCF was modeled as a dichotomy (i.e., negative or positive) and categorical 
variable (i.e., negative, very low shedder, low shedder, moderate shedder, or heavy 
shedder).  
Simple models were developed including random effects, but without additional 
covariates other than the ELISA or BCF status. Potential confounding of the association 
between test outcomes and AWW due to herd and cow-level covariates was evaluated on 
the basis of change in regression coefficients by more than 20% after inclusion of the 
covariate in the model. Age of cow, parity of cow, source of cow (i.e., purchased or 
home-raised), years since the inception of a control program, herd-size, breed, and 
testing laboratory were evaluated individually for potential confounding. Covariates that 
were not confounders were retained in the final models on the basis of reduction in the 
Bayesian Information Criterion (BIC) (Dohoo et al., 2003). The decrease in AWW was 
expressed in US Dollars based on 5-year (2007 to 2011) average feeder calf values from 
the National Agricultural Statistics Service (USDA, 2012). 
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A simple benefit-cost ratio was constructed to evaluate the effect of JD prevalence 
on the economic benefit of screening. Benefits were estimated as the possible recovery 
of the amount lost due to lowered weaning weight in calves from test-positive dams. 
Cost of testing were considered to be $9.60 and $18.00 for ELISA and BCF, respectively 
(TVMDL, 2013). Cost of labor was ignored because it was assumed that sample 
collection could be performed during annual pregnancy examinations or similar routine 
procedure. True prevalence was varied between 0 and 100% and apparent prevalence 
was estimated for serum ELISA and BCF based on reported sensitivities and 
specificities (Collins et al., 2006). Percentage of nationwide beef herds across different 
levels of true prevalence were plotted assuming 20% of the herds being infected and the 
distribution of within herd prevalence elicited by beta distribution of reported 
prevalences (Hill et al., 2003; Roussel et al., 2005). 
 
2.3 Results 
A total of 50,099 test occasions during 1999 to 2009 from 16,925 beef cattle were 
available from the 22 herds within the NJDDHP database. Total observations included 
29,455 ELISA and 20,614 BCF results. Recording of weaning weight data was optional 
for participating herds and was only available for four herds. Within these four herds, 
one did not record both the weight and age at weaning. Within the three herds with both 
weaning weight and age, the average (minimum, median, maximum) percentage of test-
positive cows in a given year was 4.0% (0%, 1.5%, 19%) for ELISA, and 0.6% (0%, 






Figure 1: Test-positive percentage of cows from beef herds tested with fecal culture 




The 4,842 cows with calf weaning age and weight data had 3,482 serum ELISA 
and 2,103 BCF test results available for analysis. Of the 5.5% (192/3482) ELISA 
positive results, 1.1% (39/3482) were strong-positive and 4.4% (153/3482) were 
positive. Of the 0.8% (17/2103) fecal culture positive results, one fecal culture positive 
observation had missing data for shedding intensity. Of the remaining 2,102 
observations, 0.2% (5/2102) were heavy shedders, 0.1% (3/2102) moderate shedders, 
0.2% (4/2102) low shedders, and 0.2% (4/2102) very low shedders. 
Data were available from a herd in Florida with 1,166 cow-AWW-test 
observations for ELISA and 454 for BCF. Of the cows with breed information, 71% 
(1000/1404) of the observations were from Angus, 1% (13/1404) Angus cross, and 28% 
(389/1404) from Brahman dams. Another herd in Florida had 1,179 cow-AWW-test 
observations for ELISA and 543 for BCF which were comprised of 21% (229/1066) 
Angus, 55% (585/1066) Angus crossbreds, and 24% (252/1066) Brahman or Brahman 
crosses. The herd from North Dakota had 1,137 cow-AWW-test observations for ELISA 
and 1,106 for BCF which were comprised of 61% (1377/2243) Angus, 32% ( 711/2243) 
Angus cross and the remainder other crosses. Both Florida herds were tested from 2002 
to 2009. The herd from North Dakota was tested from 2005 to 2009. 
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Table 3: Difference in 205-day adjusted weaning weight of calves from cows with 
positive ELISA and fecal culture results in participating beef cow-calf operations 
Model* Test type Decrease in 205-day adjusted weaning weight 
of calf† 




Fecal culture positive 27.33 12.35 to 42.31 <0.001 73.16 
ELISA positive  5.79 1.18 to 10.41 0.014 15.50 
Adjusted 
model§ 
Fecal culture positive 33.26 18.79 to 47.73 <0.001 89.01 
ELISA positive  5.53 1.05 to 10.02 0.016 14.81 
* All models included random effects for repeated tests within each cow and for cows nested within herds 
† Loss relative to test-negative classification 
‡ Based on 5 year (2007 to 2011) average feeder calf value from http://www.nass.usda.gov 




The final models included test status and fixed effects for age of dam at testing, 
parity of dam, and number of years since inception of the control program. Calves from 
seropositive dams were associated with a 5.5 kg (12.2 lb, P < 0.001) decrease in AWW 
relative to calves from seronegative dams (Table 3). This represents an average loss of 
US $15 per head among offspring of seropositive dams. Results from models with 
categorical ELISA outcomes demonstrated decreases in AWW of 21.5 kg (47.4 lb, P < 
0.001), 2.9 kg (6.3 lb, P = 0.261), and 2.8 kg (6.1 lb, P = 0.139) in offspring of strong-
positive, positive, and suspect dams, respectively, relative to calves from seronegative 
dams (Table 4). Losses in offspring of cows classified as strong-positive based on serum 
ELISA are equivalent to US $57 when sold at weaning based on average feeder calf 
values. This would support losses of approximately US $135 for an affected herd of 100 
cows at a seroprevalence of 9% (Hill et al., 2003), which corresponds to 28% true 
prevalence (Collins et al., 2006).  
Calves born to dams with positive BCF for MAP were associated with a decrease 
in average AWW of 33.3 kg (73.3 lb, P < 0.001) corresponding to a loss of US $89 per 
affected calf (Table 3). When BCF outcomes were classified based on level of shedding, 
the heavy, moderate, low, and very low shedders produced calves with average AWW 
58.5 kg (129.0 lb, P < 0.001), 40.8 kg (90.0 lb, P = 0.016), 17.8 kg (39.3 lb, P = 0.284), 
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and 12.8 kg (28.1 lb, P = 0.395) lighter than non-shedders, respectively (Table 5). 
Associated economic losses were US $156, US $109, US $48 and US $34 among calves 
from heavy, moderate, low and very low shedders, respectively.  
 
 
Table 4: Reduced weaning weights in calves from cows with different levels of 
ELISA test results in participating beef cow-calf operations  
Model* ELISA results Decrease in 205-day adjusted weaning weight of calf† 




Strong-positive 22.45 12.75 to 32.15 <0.001 60.10 
Positive 2.83 -2.32 to 7.99 0.282   7.58 
Suspect 3.35 -0.40 to 7.09 0.080   8.96 
Adjusted 
model§ 
Strong-positive 21.48 11.66 to 31.30 <0.001 57.49 
Positive 2.85 -2.13 to 7.99 0.261   7.64 
Suspect 2.78 -0.90 to 7.84 0.139   7.43 
* All models included random effects for repeated tests within each cow and for cows nested within herds 
† Loss relative to test-negative classification 
‡ Based on five year (2007 to 2011) average feeder calf value from http://www.nass.usda.gov 




Table 5: Reduced weaning weights in calves from cows with different levels of fecal 
test results in participating beef cow-calf operations 
Model* Fecal  
culture 
results 
Decrease in 205-day adjusted weaning weight of calf† 
Kg 95% CI, kg P-value US$ Value‡ 
Simple model 
 
Heavy 57.25 29.49 to 85.00 <0.001 153.22 
Moderate 34.99 -0.38 to 70.36 <0.053   93.65 
Low 9.83 -20.49 to 40.16 0.525   26.32 
Very low 11.04 -20.37 to 42.46 0.491   29.56 
Adjusted 
model§ 
Heavy 58.51 32.50 to 84.53 <0.001 156.60 
Moderate 40.81 7.64 to 73.99 0.016 109.23 
Low 17.81 -14.76 to 50.37 0.284   47.66 
Very low 12.75 -16.63 to 42.13 0.395   34.12 
* All models included random effects for repeated tests within each cow and for cows nested within herds 
† Loss relative to test-negative classification 
‡ Based on five year (2007 to 2011) average feeder calf value from http://www.nass.usda.gov 




An economic benefit of BCF testing was observed at a true prevalence of 31% or 
greater (Figure 2) and this corresponds to a BCF apparent prevalence of at least 20%. 




Figure 2: The effect of true prevalence on the benefit-cost ratio of screening a beef 
herd for Mycobacterium avium subspecies paratuberculosis. Plot of the estimated 
frequency distribution of US beef cow-calf herds by true prevalence of MAP-infected 
cattle within the herd (solid open line) with the results of the benefit-cost ratios for 
screening individual beef cows for MAP by serum ELISA (dotted line) or BCF (solid 





Lower AWW is a primary economic concern for many commercial beef cow-calf 
producers because the weight of calves sold at weaning is often the most important 
component of herd income. Lower weaning weights can be a consequence of production 
inefficiencies in the dam including lower milk yield (Johnson-Ifearulundu et al., 1999; 
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Johnson-Ifearulundu et al., 2000; Manning and Collins, 2001; Gonda et al., 2007; 
Benedictus et al., 2008; Raizman et al., 2009) and thus reduced plane of nutrition in the 
calf (Roussel, 2011). Direct impacts on AWW are unlikely in infected calves given the 
prolonged latency of MAP infection (Chiodini et al., 1984; Harris and Barletta, 2001). 
Substantial compensatory post-weaning weight gain would be necessary for offspring of 
test-positive cows to achieve similar performance as calves from other herd mates. 
However, severe or chronic retardation in growth in early life is associated with lighter 
weight at all ages (Greenwood, 2006) indicating that the time required to achieve a 
desired endpoint may be extended for these animals.  
Results from this study demonstrate a significant reduction in AWW in the 
offspring of cows positive for MAP via BCF or serum ELISA, particularly those 
classified as having either high levels of serum antibody or shedding high levels of MAP 
in their feces. A previous study reported a reduction in AWW of 2.3 kg (95% CI: 0.5 to 
4.1 kg) in calves from suspects (ELISA score 1) and of 6.9 kg (95% CI: 1.6 to 12.2) in 
calves from strong-positive (ELISA score 3) cows (Elzo et al., 2009). The differences 
between the work presented here and the prior study may be attributed to their use of 
ELISA score as a linear covariate whereby scores of 1, 2 or 3 would be associated with 
reductions in AWW of 2.3 kg, 4.6 kg, and 6.9 kg, respectively. The current analysis 
modeled ELISA scores as discrete categories and the difference in AWW observed here 
did not approximate a linear relationship.  
The decreases in AWW were higher with increasing ELISA scores and levels of 
MAP shedding in the feces. Similar estimates of reduced AWW between fecal culture 
positive and strong ELISA positive cows is likely due to an increasing probability that 
both conditions represent truly infected cows in more advanced stages of disease (lower 
probability of false-positive results). Classification of tested cows in two categories (i.e., 
positive and negative) appears to be less discriminating relative to impacts on AWW, 
especially for ELISA, presumably due to greater propensity for false positive outcomes. 
However, a fecal culture positive animal, irrespective of the shedding intensity, is a 
persistent threat of new infections in the herd.  
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Our results demonstrate measurable losses in the weaning weight of calves 
estimated for different cow-test outcomes. Although reduced weaning weight of calves 
may be the primary economic concern for cow-calf producers, premature culling of 
affected cows and lowered weight of culled animals contribute to the cumulative 
economic effect at the herd level. There are also losses associated with longer open 
period, reduced weight of offspring (Elzo et al., 2009), increased mortalities and loss of 
revenue, negative impacts on the reputation of seedstock producers (Roussel, 2011)  
Other potential economic consequences not readily estimable include loss of valuable 
genetics, potential litigation (Roussel, 2011), as well as contamination of land, market 
discrimination and legal liabilities (Kennedy and Allworth, 2000). 
Failure to offset the costs of ELISA testing in a herd at any prevalence is due to 
the small difference in weaning weight between calves from ELISA positive and 
negative dams. Therefore, this simple estimate should only be used as a basic guideline 
until more comprehensive estimates are available. 
A limitation of this study is that the weaning weight could not be adjusted for 
birth weight, which was available for very few observations in the database. Estimation 
of adjusted weaning weight accounts for birth weight among healthy animals. However, 
infected dams might have lower weight calves and therefore adjustment for birth weight 
might remove some of the effect associated with dam’s infection status. Conclusions 
based on these results thus represent overall loss in weaning weight rather than effects 
on pre-weaning weight gain. Comparison of differences in weaning weights of calves 
from cows with and without clinical signs indicative of JD was not possible in the 
current study because weaning weight was available for only a single calf with a dam 
exhibiting clinical signs consistent with JD. Weaning weight data from 19 of 22 enrolled 
herds could not be used for analysis because weaning weight, dates, calving season and 
sex were not recorded.  
There is potential selection bias associated with sourcing data for analysis from 
the NJDDHP as these three herds may not reflect the entire U.S. beef cattle industry in 
general. In order to participate in the NJDDHP, herds needed to be MAP-positive as 
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determined by an organism detection test. Producers who opted to record accurate 
weaning weight data for the herds used in this analysis may be more concerned about 
JD. The conclusions that test-positive cows produce a lighter calf is likely to be true 
across non-enrolled beef cow-calf herds, but the magnitude may be different based on 
animal and herd-level factors not evaluated in this study. These limitations may affect 
the external relevance of reported results. The overall test-positive percentage in herds 
included in this study is similar to that reported from beef herds across the US (Thorne 
and Hardin, 1997; NAHMS, 1999; Hill et al., 2003; Roussel et al., 2005). Different 
diagnostic laboratories were used but all were accredited to meet certain pre-determined 
standards (USDA, 2010) to ensure reproducible results. 
Efforts to control JD are hindered by the limitations due to a lack of proven 
preventive practices and difficulties in diagnosis including lack of a gold standard 
(Wang et al., 2006), low sensitivities of available tests (Kudahl et al., 2007b; Kudahl et 
al., 2008), and potential for impaired test specificity attributed to exposure to 
Mycobacteria spp. other than MAP (Osterstock et al., 2007; Roussel et al., 2007). As 
demonstrated in this study, the greatest decreases in AWW were observed among 
offspring of heavy shedders and cows with high serum antibody titers to MAP. This has 
important implications for commercial cow-calf producers that desire a method to 
minimize economic losses associated with JD as opposed to disease eradication. Testing 
programs designed to reduce economic losses may choose to emphasize detection of 
cattle with the greatest likelihood of MAP infection based on higher ELISA titer or 
heavy fecal shedders. In the absence of regulatory components or market assurance and 
incentives for low-risk herds, dissemination of information about potential economic 
losses including those reported here will be important to help producers appreciate the 
impact of JD in infected herds. This may motivate greater interest in developing and 
sustaining testing and control programs.  
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3. PERCEPTIONS OF VETERINARIANS AND PRODUCERS CONCERNING 




Mycobacterium avium subspecies paratuberculosis (MAP) is the etiologic agent 
of bovine paratuberculosis commonly known as Johne’s disease (JD). In cattle, JD is 
characterized by a chronic granulomatous ileocolitis, a long pre-clinical phase 
terminating in diarrhea, debilitation (Chiodini et al., 1984; Harris and Barletta, 2001), 
cachexia and death (Manning and Collins, 2001). Reported estimates of the prevalence 
of MAP infected beef cattle and herds in the United States vary widely, ranging from 
0.4% to 9% of animals and 8% to 63% of herds based on detection of MAP-specific 
antibodies in serum (Thorne and Hardin, 1997; NAHMS, 1999; Dargatz et al., 2001; Hill 
et al., 2003; Roussel et al., 2005).  
The Beef' ’97 and Beef 2007-08 studies by the National Animal Health 
Monitoring System (NAHMS) estimated that 92% and 69%, respectively, of beef 
producers were unaware of JD or only recognized the name without having direct 
knowledge about the disease (NAHMS, 1999). The United States Voluntary Bovine JD 
Control Program (VBJDCP) was implemented to provide minimum national standards 
for the control of JD and to educate veterinarians and producers regarding management, 
prevention and control of JD (VBJDCP, 2002). A survey in Texas during 2006 
suggested that only 20% of beef producers were familiar with the VBJDCP and 16% 
considered participation (Benjamin et al., 2010). Sixty-four percent of veterinarians in 
Texas had educated beef producers on management strategies for the control or 
elimination of JD. However, only 36% of these veterinarians had received specific 
training regarding JD epidemiology and 29% were JD-certified (Benjamin et al., 2010).  
The objective of this study was to compare the perceptions of producers and 
veterinarians on the burden of MAP infection in cow-calf herds and measures to control 
new infections using responses from mailed questionnaire surveys. A secondary 
 44 
 
objective was to compare the differences in perceptions among different types of cow-
calf producers and veterinarians to identify the differences in knowledge about JD in 
field condition. 
 
3.2 Materials and methods 
The study protocol was approved by the Institutional Review Board at Texas 
A&M University (protocol number 2010-06666).  
 
3.2.1 Questionnaire development  
Questionnaires were developed to investigate the perceptions of veterinarians and 
producers regarding the burden of JD and potential control measures. Questions 
concerning biosecurity and pathogen reduction were based on the recommendations 
from “How to Do Risk Assessments and Management Plans for Johne’s Disease” 
(VBJDCP, 2002).  
The beef producer questionnaire contained 31 questions with applicable sub-
questions in three major sections. The first section considered general herd information. 
The second section included questions about disease burden, perceived losses and 
differences between the productivity of MAP infected and non-infected cattle, possible 
costs associated with implementing control programs, facility upgrades deemed 
necessary for testing, and herd health management. The final section included questions 
related to activities for the control of MAP transmission.  
The majority of questions for the veterinarian questionnaire were designed to be 
comparable to those in the producer questionnaire. There were three major sections with 
35 main questions with some sub-questions, and two open ended questions for 
explanations related to preceding questions. The first section considered general 
demographic information including type and size of the veterinary practice. The second 
part was related to estimating disease burden in practice clientele herds, perceived 
losses, and differences between the productivity of MAP infected and non-infected 
cattle. The final section included questions related to control of MAP transmission in 
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client herds. The veterinarian questionnaire was pre-tested by administration to bovine 
practitioners in the listserv of a professional organization via the internet and revised 
based on the responses and comments.  
Both questionnaires utilized a combination of free numerical or text responses, 5-
category Likert scales, dichotomies (yes/no), and multiple choice questions. Both 
questionnaires were designed to be completed within 30 minutes. All questionnaires 
were printed in booklet form with a page containing survey information, rights of the 
respondents, and ethical approval. The survey packet also included a signed cover letter 
that described the purpose of the questionnaire. Guidelines for completing the 
questionnaire were explained in the cover letter and information sheet.  
 
3.2.2 Survey administration 
Surveys were mailed during November and December, 2010 to all beef 
producers that had risk assessments performed and herd management plans developed 
for JD. Participants were contacted by the Designated Johne’s Coordinates (DJCs) of 
nine states in the USA (FL, GA, IA, MO, ND, SC, SD, WI, WV). Sample size 
calculation was not performed since all eligible participants were selected for the survey. 
A personal cover letter from the State DJCs was included with the questionnaire booklet. 
Introductory letters prior to the questionnaire, incentives and reminders were not sent to 
producers because information concerning questionnaire recipients was not disclosed to 
investigators.  
Veterinarians with active membership in a nationwide professional organization 
who listed “bovine” as one of their practice types as of July 2011 served as the sampling 
frame. Sample size calculation was not performed because it was decided to contact all 
listed veterinarians satisfying the inclusion criteria from the same nine states used for the 
producer survey. Surveys were uniquely coded to protect confidentiality. Veterinarians 
were contacted with an introductory letter 12 days prior to the mailing of questionnaires. 
Reminder post-cards were mailed eight days after the questionnaire. A business reply 
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envelope and a $2 bill were included in each questionnaire packet as an incentive to 
improve response proportions (Bhattarai and Fosgate, 2010). 
 
3.2.3 Analysis 
Responses from the completed questionnaires were recorded on a secure server 
using SelectSurvey (ClassApps.com, 2006, SelectSurvey.NET 1.5.1). Unsolicited 
personal information revealed by some producers in free text comments were not 
recorded in the database. Data were analyzed using Stata® (StataCorp. 2011. Stata® 
Statistical Software: Release 11.2. College Station, TX: StataCorp LP) and OpenEpi 
(Dean et al., 2011). Continuous outcomes were reported with mean, minimum, median, 
and maximum values. Wilcoxon rank-sum tests were used to compare variables not 
normally distributed based on the Shapiro–Wilk test. Two-sided statistical tests were 
performed and results were interpreted at the 5% level of significance.  
Responses regarding whether the herd was ever tested for JD or currently 
enrolled in any JD control program were compared between respondents with and 
without specific herd types. Burden of MAP infection in producer herds and veterinarian 
client herds were summarized and compared among types of herds. Likert scale 
responses concerning the frequency of selected disease control activities performed by 
producers and perceived by veterinarians were dichotomized. The “always” and 
“mostly” categories were collapsed into a single “yes” category and the categories 
“seldom” and “never” were collapsed into “no.” The category “sometimes” was handled 
as missing data. Frequencies of these activities performed with intent of controlling JD 
were evaluated using odds ratios with corresponding 95% confidence intervals and mid-
point exact P values. Three herd size categories were created with each group having an 
approximately equal number of observations: small (<50 head), medium (50-149 head) 
and large (≥150 head) herds. 
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3.3 Results  
3.3.1 Description of producers 
Questionnaires were mailed to 989 cow-calf producers. Twenty-four 
questionnaires were undeliverable due to incorrect addresses. The response proportion 
was 17% with 160 questionnaires returned. The average (minimum, median, maximum) 
herd size was 155 head (3, 70, 2500). Thirty-five percent (54/155) of herds had less than 
49 adult cows, 35% (55/155) of herds had 50 to 149 cows and 30% (46/155) of herds 
had 150 or more cows. Average (minimum, median, maximum) number of years in the 
cow-calf business was 32 (6, 32, 83) years. Angus was the predominant breed reported 
by 52% (81/156) of respondents. A total of 58% of producers had commercial cow-calf 




Table 6: Description of the herds of producers (n=160) and client herds of 
veterinarians (n=325) who responded to Johne’s disease questionnaire survey 
Variables Producers Veterinarians 
Number (%) of herd types   
Commercial cow calf - registered 37 (23.1) 224 (70.2) 
Commercial cow-calf not registered 64 (40.0) 275 (86.2) 
Seedstock registered 86 (53.8) 189 (59.3) 
Seedstock not registered 10 (6.3) 107 (33.5) 
Feedlot 0 184(57.8) 
Backgrounder, stocker and dairy herds 0 64 (20.1) 
Herd attributes   
Average herd size (min, median, max) 155 (3,70,2500) 105 (0,50,3000) 
Percentage of infected herds 21.9 26.3 




Ninety-five percent (149/157) of producers had tested their herds for JD at least 
once and 74% (117/158) of producers were currently enrolled in either VBJDCP or had 
some JD control program designed by their veterinarian. A total of 89% (100/113) of 
enrolled producers also indicated that they were in the VBJDCP. The average 
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(minimum, median, maximum) number of years since the inception of a control program 
was seven (1, 6, 30) years. Thirty-eight percent (56/149) of respondents maintained a 
closed herd. Seedstock producers were four times more likely (P< 0.01) to be currently 
enrolled in a JD control program compared to non-seedstock producers. Enrollment was 
ten times less likely (P< 0.01) in producers with commercial cow-calf herds, and three 




Table 7: Involvement of US beef cow-calf producers in Johne’s disease testing, 
enrollment in a control program and maintenance of a closed herd during 2010-
2011 
Variable  Odds 
ratio 
95% CI Pa 
Tested herd for MAP Yes No    
Commercial cow-calf 
Yes 85 7 
0.19 0.02 to 1.58 0.099 
No 64 1 
Seedstock 
Yes 86 3 
2.28 0.52 to 9.87 0.292 
No 63 5 
Closed herds 
Yes 52 4 
0.59 0.14 to 2.49 0.499 
No 87 4 
With clinical cow 
Yes 23 4 
0.25 0.05 to 1.20 0.101 
No 69 3 
Enrolled in a control program Yes No    
Commercial cow-calf 
Yes 56 37 
0.10 0.03 to 0.30 <0.001 
No 61 4 
Seedstock 
Yes 76 13 
3.99 1.87 to 8.53 <0.001 
No 41 28 
Closed herds 
Yes 42 14 
1.12 0.52 to 2.39 0.780 
No 67 25 
With clinical cow 
Yes 14 13 
0.35 0.14 to 0.89 0.031 
No 55 18 
Maintained a closed herd Yes No    
Commercial cow-calf 
Yes 37 50 
1.68 0.84 to 3.33 0.145 
No 19 43 
Seedstock 
Yes 31 54 
0.90 0.46 to 1.75 0.749 
No 25 39 
With clinical cow 
Yes 8 15 
0.98 0.36 to 2.64 0.975 
No 24 44 
a Mid-point exact P values
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3.3.2 Description of veterinarians 
Surveys were sent to 1080 veterinarians. Thirty-one questionnaires were 
undeliverable due to incorrect addresses. A total of 382 questionnaires were returned but 
57 of them lacked useful information. The most common reasons for not completing the 
questionnaire were that the respondents were not currently involved in beef practice 
(n=24), there were no cattle (dairy or beef) clients in the practice (n=23) and the 
respondents were retired (n=20). Twenty-eight of these veterinarians also returned the $2 
incentive along with the reason for not completing the survey. The overall response 
percentage based on questionnaires that were useful for analysis was 31%. 
Forty-one percent (132/325) of veterinarians reported that they currently are or 
were JD certified and 38% (121/317) had performed a JD risk assessment. One or more 
risk assessments for JD were performed by 62% (78/126) of JD certified veterinarians 
and by 22% (42/190) of veterinarians that had never been certified. Eighty-eight percent 
(279/318) of veterinarians currently served cow-calf herds and 7% (22/318) of 
respondents had cow-calf clients in the past. Average (minimum, median, maximum) 
number of herds served by respondents as the primary veterinarian was 58 (0, 30, 1000). 
Average size of herds currently served by veterinarians was 105 (0, 50, 3000).  
A total of 65% (200/306) of veterinarians reported Angus as the predominant 
breed in client herds and another 19% (59/306) listed Angus as the second most common 
breed. Unregistered cow-calf operations (86%; 275/319) were the most frequent type of 
herds served by veterinarians followed by registered commercial cow-calf (70%), 
registered seedstock (59%), and unregistered seedstock operations (34%). Feedlot 
operations were clients of 57% (184/319) of veterinarians and 20% (64/319) of 
veterinarians also had backgrounder, stocker or dairy clients. 
 
3.3.3 Burden of MAP infection 
Twenty-two percent (34/155) of producers reported having infected animals in 
their herds. Average (minimum, median, maximum) prevalence reported by producers 
was 0.8% (0, 0, 10). Basis of estimation for the percentage of infected animals by 
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producers was personal experience (n=51), veterinarian’s opinion (n=51), and an 
extrapolation from local and regional data (n=4). Of the producers who wrote a free-text 
response, 87% (110/127) also mentioned a formal testing process as the basis for 
estimation. In tested herds, the average reported apparent prevalence was 2% (0, 0, 100). 
A total of 27% (27/100) of producers had at least one animal with clinical signs 
suggestive of JD during the previous year. The average frequency of clinical animals 
calculated using the number of reported clinical animals divided by herd size was less 




Table 8: Burden of Mycobacterium avium subspecies paratuberculosis infection in 
cow-calf operations reported by US beef cow-calf producers 
Herd type Responses Median (IQR) of 
Non zero responses (%) 
Range of all 
responses (%) 
Pa 
 Total Non-zeros  
Prevalence       
Seedstock 86 17 2 (1 to 4) 0 to 10 0.381 
Non-seedstock 69 17 3 (1.5 to 5) 0 to 10 
Closed herds 55 9 1 (0.5 to 4) 0 to 8 0.184 
Open herds 90 22 2.8 (1.5 to 5) 0 to 10 
Enrolled herds 114 23 2(1 to 4) 0 to 8 0.287 
Not-enrolled herds 41 11 4 (1 to 10) 0 to 10 
Clinical animals       
Seedstock 53 10 0.010 (0.006 to 0.017) 0 to 0.04 0.045 
Non-seedstock 44 16 0.013 (0.005 to 0.030) 0 to 0.2 
Closed herds 32 8 0.007 (0.006 to 0.08) 0 to 0.031 0.883 
Open herds 59 15 0.014 (0.005 to 0.033) 0 to 0.2 
Enrolled herds 67 13 0.011 (0.006 to 0.016) 0 to 0.111 0.011 
Not-enrolled herds 30 13 0.015 (0.006 to 0.029) 0 to 0.2 
Test-positive animals      
Seedstock 80 13 1.5 (1 to 3) 0 to 100 0.005 
Non-seedstock 55 21 2 (1 to 5) 0 to 100 
Closed herds 49 10 1.1 (1 to 5.5) 0 to 100 0.300 
Open herds 78 22 2 (0.8 to 5) 0 to 100 
Enrolled herds 105 18 1.75 (1 to 4) 0 to 100 <0.001 
Not-enrolled herds 30 16 1.8 (0.9 to 5.25) 0 to 100 




The odds of testing the herd for MAP and enrolling in a control program were 
lower for commercial cow-calf herds compared to producers without commercial cow-
calf herds (Table 7). Compared to non-seedstock herds, seedstock herds had a higher 
percentage of test-positive animals (P <0.01, Table 8), but a lower percentage of clinical 
cows (P<0.05). Compared to herds not enrolled in a control program, enrolled herds had 
a lower percentage of test-positive cows (P<0.01) and a lower percentage of clinical 
animals (P=0.01). Average test-positive percentage, and prevalence estimated by 
producers were higher in medium (50-149 head) and highest in large (≥150 head) herds. 
Compared to small herds (<50 head), the odds of having a clinical animal were four 




Table 9: Burden of Mycobacterium avium subspecies paratuberculosis infection in 
cow-calf operations reported by the US cow-calf veterinarians 
Respondent type Responses Median (IQR) 
of non-zero 
responses(%) 






Cattle infected with MAP in practice clientele  
JD certified 109 105 2 (1–5) 0–60 
0.483 
Not certified 162 154 2 (1–5) 0–30 
Performed risk assessment 111 109 2 (1–5) 0–50 
0.723 
Did not perform risk assessment 154 144 3 (1–5) 0–60 
Client herds with animal(s) infected with MAP  
JD certified 110 106 20 (5–50) 0–100 
0.006 
Not certified 166 156 10 (3–34) 0–100 
Performed risk assessment 112 110 15 (5–50) 0–100 
0.010 
Did not perform risk assessment 158 146 10(2–50) 0–100 
Infected cattle within MAP infected client herd    
JD certified 107 107 5 (3–10) 1–80 
0.454 
Not certified 154 154 5 (2–10) 0.01–40 
Performed risk assessment 111 111 5 (2–10) 0.05–80 
0.268 
Did not perform risk assessment 143 143 5(3–10) 0.01–70 
a Wilcoxon rank-sum test based on all responses 
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Table 10: Frequency of activities performed by cow-calf producers with clinical 
cattle and perceived by veterinarians to be performed by producers with the sole or 
a partial intent of controlling Johne’s disease  
Activities to control 
Johne’s disease (JD): 
Respondent Yes No Odds 
ratio 
95% CI Pa 
Remove calves from dams 
suspected of being infected 
with MAP prior to nursing 
Producers 3 23 
1.33 0.37 to 4.80 0.642 
Veterinarians  21 214 
Cull cows showing signs 
consistent with a diagnosis 
of JD prior to testing 
Producers  15 7 
0.48 0.18 to 1.26 0.154 
Veterinarians  165 37 
Cull cows with signs 
consistent with a diagnosis 
of JD after laboratory 
testing 
Producers  19 7 
0.19 0.07 to 0.52 0.003 
Veterinarians  240 17 
Cull calves from dams 
suspected or confirmed to 
be infected with MAP 
based on testing or clinical 
signs 
Producers  15 9 
1.44 0.60 to 3.46 0.419 
Veterinarians  105 91 
Early weaning of calves 
from dams with positive 
results from JD-tests 
Producers  7 13 
1.82 0.68 to 4.83 0.245 
Veterinarians  45 152 
Cull cows without clinical 
signs consistent with a 
diagnosis of JD, but 
positive serology (ELISA) 
Producers  14 8 
1.96 0.79 to 4.88 0.153 
Veterinarians  92 103 
Test purchased additions 
for JD 
Producers  6 14 
5.19 1.77 to 15.24 0.007 
Veterinarians  17 206 




Average animal level prevalence (minimum, median, maximum) reported by 
veterinarians for their client herds was 5% (0, 2, 60). Average percentage of herds with 
at least one infected animal in client herds was 26% (0, 10, 100). Average reported 
percentage of infected cows within infected herds was 9% (0.01, 5, 80) (Table 9). 
Percentage of client herds with at least one infected cow were reported to be higher by 
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JD certified veterinarians (P<0.01) and veterinarians who had performed a risk 
assessment (P=0.01). The methods used by veterinarians to derive these estimates were 
the number of animals with clinical signs of JD (62%, 237/382), ELISA results (44%, 
169/382), fecal culture results (27%, 103/382), and an extrapolation from regional or 
national data (13%, 51/382).  
 
3.3.4 Management and testing 
Although 95% of producers had tested their herds at least once, only 30% of 
producers with clinical animal(s) in their herd tested purchased additions, 35% weaned 
calves early from test-positive dams, and 12% removed calves from JD suspect dams. 
Compared to veterinarians’ perceptions, producers were less likely to cull cows with 
signs consistent with JD (P<0.01), but more likely to test purchased additions for JD 
(P<0.01, Table 10). Veterinarians also reported that only 8% of their clients tested 
purchased additions for JD. 
Miscellaneous free-text comments from producers indicated that some purchased 
only pre-tested cattle from trusted or test-negative herds. One producer not only tested 
every purchased addition but also segregated those animals for six months. Producers 
were not specifically asked about the disposition of cows with clinical signs consistent 
with JD, but three producers noted that they culled such cows. A producer also reported 
that they would remove or destroy all suspect cows. Regarding the disposition of calves, 
one producer wrote that calves from infected dams are not retained as replacements and 
are marketed as feeder cattle. Another producer raised replacement heifers separately 
until three years of age. One producer noted that breeders should be encouraged, if not 
required, to only sell bulls and replacement females that are from test-negative dams. 
Another producer had a strong belief that MAP transmission is due to the reuse of 
palpation gloves during pregnancy diagnosis. One producer also mentioned that their 
management and facilities were designed to control JD by elevating feed bunks and 
reducing stocking density within winter feeding areas. 
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Questions regarding recommendationded test(s) by veterinarians (n=277) for the 
initiation of a testing program in beef cow-calf herds allowed multiple responses. The 
responses were bacterial culture of feces (3%), polymerase chain reaction (PCR, 14%), 
enzyme linked immunosorbent assay (ELISA, 35%) and a combination of these tests 
(47%). The recommended interval between testing was 12 months by 79% (198/252) of 
respondent veterinarians. Eleven percent (28/252) of veterinarians recommended testing 
every six months while one respondent recommended testing more frequently than six 
months. Three percent (8/252) of veterinarians recommended 18 months, 7% (18/252) 
recommended testing interval of more than 18 months, and 3% (7/252) of respondents 
did not believe periodic testing was necessary. A total of 46% (124/270) of respondents 
preferred combination of ELISAs with PCR or fecal culture for herds starting a testing 
program. Thirty-four percent (42/136) of these respondents preferred a combination of 
tests based on the assumption that it would improve sensitivity, specificity or 
“accuracy.” Thirty-six percent (97/270) of veterinarians preferred ELISA because it is 
rapid (49%, 48/97), inexpensive (46%, 45/97), and easy (38%, 37/97) for whole herd 
screening.  
 
3.4 Discussion  
Seedstock producers were more likely to enroll in a JD control program. This can 
be related to an overall awareness of seedstock producers concerning the importance of 
improved herd health for better economic outcomes. The average value of animals in a 
seedstock herd is typically higher than those in commercial cow-calf operations. 
Seedstock producers were also more likely to purchase additions compared to non-
seedstock producers which increases risk of introduction of infected animals.  
The producer estimated average cow-level prevalence was 0.8%. Similarly, a 
nationwide study estimated that 0.4% of US beef cattle were seropositive (NAHMS, 
1999; Dargatz et al., 2001). Other studies have reported a seroprevalence of 3% (Roussel 
et al., 2005), 5% (Thorne and Hardin, 1997), and 9% (Hill et al., 2003) and this suggests 
that the true prevalence may be 7% to 28% after adjustment for the sensitivity and 
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specificity of available serum ELISAs (Collins et al., 2006). Producers with infected 
herds (22%) and the average percentage of infected herds estimated by veterinarians 
(26%) were lower than previous field studies. Forty percent of beef herds in Missouri 
(Thorne and Hardin, 1997), 44% of herds in Texas (Roussel et al., 2005), and 63% of 
herds in Alabama (Hill et al., 2003) have been reported as seropositive for JD. The 
perception that there is a higher percentage of infected herds by veterinarians with JD 
certification or risk assessment experience might be due to a better understanding of 
disease burden. Another possible explanation towards this perception is that producers 
suspecting that their herd is infected might seek the services of a JD certified 
veterinarian. Some differences in perceptions are expected because published reports 
were based on seroprevalence, while respondents answered based on test results, 
regional or national data, and experience. Furthermore, veterinarians estimated the 
prevalence based on a typical client herd rather than the testing of a specific herd. The 
majority of producers had tested their herd, or a part of the herd in the past, but their 
responses were not necessarily an accurate representation of this test-based prevalence. 
Commercial cow-calf producers were less likely to enroll in a control program 
compared to producers without commercial cow-calf herds. Commercial cow-calf 
producers tended to maintain a closed herd, which may enable producers to eliminate 
contamination from additions. A lower comparative prevalence in closed herds also 
suggests reduced probability of introduction of infected stock. In a previous study, only 
25% of the producers perceived significant financial and non-financial benefits 
associated with participation in the VBJDCP (Benjamin et al., 2009) and those results 
were from producers with an extremely low probability of having MAP infected cows in 
the herd (classification Level 4). Although 84% (46/55) of closed herds were already 
reported to be infected, maintaining a closed herd is an effective method to prevent 
further introduction of infected cows. Mixing replacement heifers from different 
production units without known low-risk status might also increase exposure and chance 
of transmission from subclinically infected animals (Sweeney, 1996; Kovich et al., 
2006). Excluding dairy cattle and ensuring more effective farm biosecurity will reduce 
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the risk of introducing MAP infection into beef herds (Larsen et al., 2012). Strict 
biosecurity by not allowing infected cattle to enter the farm is the only necessary control 
measure for uninfected herds (Roussel, 2011). 
Compared to small herds (<50 head), test-based prevalence and producers’ 
estimates of the herd prevalence were higher in medium sized herds (50-149 head) and 
highest in large (≥150 head) herds. The odds of having a cow with clinical signs of JD 
were higher in larger herds, possibly due to an increased probability of detecting rare 
events in larger herds. Larger herds might also be more likely to have a higher MAP 
infection prevalence because of an expected higher rate of animal movements and 
increased density of animals in areas where cattle congregate for feed, water, and shade 
(Sweeney, 1996). Only 63% (100/160) of producers answered the question concerning 
having a cow with clinical signs during the previous year. The true percentage of herds 
with clinical animals during the previous year might have been lower than estimated 
because producers who left the answer blank (handled as missing data) might have had 
no clinical animals. Most herds with clinical JD reported having only a single case in the 
previous year.  
The number of producers employing herd testing was higher among those 
enrolled in a control program. Ninety-five percent of herds were tested for MAP at least 
once although only 74% of producer respondents were currently enrolled in a control 
program. Disinclination from regular testing may be attributed to the low sensitivity of 
available tests (Wang et al., 2006; Benedictus et al., 2008). One respondent producer 
commented that until a test is developed that is more than 50% accurate it would be 
“stupid and irresponsible” to perform the management practices proposed in the 
questionnaire. While it is true that test sensitivities are low, perhaps this illustrates that 
producers do not have an adequate understanding of test interpretation and the 
importance of herd hygiene.  
Responses from veterinarians regarding testing were mostly in favor of ELISA 
for herds starting a control program. Fecal culture is considered more sensitive and 
specific than ELISA (Collins et al., 2006; van Schaik et al., 2007b) although it is costly 
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and there is a long delay in the availability of results due to the slow growth of MAP in 
culture (Kudahl et al., 2007b). The majority of respondent veterinarians recommended a 
12-month interval similar to the VBJDCP (USDA, 2002, 2005, 2010). Specific client 
and herd needs may warrant a different test type and interval. One producer 
implemented 6-monthly intervals when testing was subsidized by the program.  
Testing purchased additions was a preferred practice for only 30% of producers 
and 8% of veterinarians. One of the most important routes of transmission between herds 
is the addition of subclinically infected animals (Sweeney, 1996). In Canadian dairy 
herds, ELISA-seropositivity was significantly associated with "open heifers purchased 
during the last 12 months" (Tiwari et al., 2009). While producers in general appeared 
less concerned about infected replacements, one respondent tested and quarantined 
additions for six months before mixing into the herd. One of the reasons for not testing 
additions was that some producers only purchased animals from herds with known JD-
low-risk status. In Canada, veterinarians perceived that less than half of beef producers 
would prefer purchasing replacements from herds where a risk assessment had been 
performed (Sorge et al., 2010).  
The immediate removal of calves from an infected dam was only practiced by 
12% of producers and perceived to be performed by 9% of veterinarians. Cow-to-calf 
transmission occurs most commonly within the calving area and this would be expected 
to reduce the risk of transmission (Benedictus et al., 2008; Windsor and Whittington, 
2010). Producers within the VBJDP are educated concerning possible routes of cow-to-
calf transmission during enrollment into the program (USDA, 2010). More than half of 
the responses from both producers and veterinarians favored culling calves based on a 
positive test or suspect clinical signs in the dam. One producer indicated that such calves 
can still be fattened and sent to slaughter, which would be economically more rewarding 
than immediate removal.  
A major limitation of this study is the exclusive enrollment of producers who had 
on-farm risk assessments performed and herd management plans developed. Only 17% 
of the producers and 31% of veterinarians responded to the questionnaires and this 
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indicates a possibility of non-response bias. Information regarding non-responders was 
not available and the impact of this potential bias could not be assessed. Comparability 
was attempted by recruiting producers and veterinarians from the same nine states, but 
respondent veterinarians might not have served the producers included in this study. 
Only producers with clinical cows during the previous year were included in the analysis 
of disease control activities because such activities would not be applicable to JD-free 
herds. However, only 27 herds had clinical animals leading to a lower precision of 
estimated measures of association.  
The percentage of producers currently enrolled in a control program among the 
responders of this study (75%) is quite high because the DJCs in each state contacted the 
producers who had had risk assessments performed in their herds. Therefore, these 
producers presumably have more knowledge concerning JD than US beef producers in 
general. The power to detect statistical significance for some associations was low due to 
limited numbers. A few of the associations might be counterintuitive. Seedstock 
producers were more likely to have uninfected herds even though they were more likely 
to introduce new animals onto their premises (maintain an open rather than closed herd). 
A possible explanation is that the infected seedstock producers did not adopt a formal 
control program because they feared lack of confidentiality. Closed commercial cow-calf 
herds were more likely to have infected and clinical cows despite the protection from JD 
introduction via MAP infected purchased animals. There is the possibility that the herd 




4. PERCEPTIONS OF VETERINARIANS AND PRODUCERS CONCERNING 




Johne’s disease (JD), or paratuberculosis, caused by infection with 
Mycobacterium avium subspecies paratuberculosis (MAP) is a disease of worldwide 
economic importance (Johnson-Ifearulundu et al., 1999; Harris and Barletta, 2001). 
Infection with MAP causes reduced production in dairy herds (Ott et al., 1999; Harris 
and Barletta, 2001; Tiwari et al., 2008; Raizman et al., 2009). Mortalities and sale of 
underweight infected cows represent a loss of revenue for beef producers and may have 
negative impacts on the reputation of seedstock producers (Roussel, 2011). There are 
negative impacts related to regulatory and ethical issues (Rossiter and Burhans, 1996) as 
well as legal liabilities for the sale of an infected cow, contamination of land, and 
breeding animals from infected herds (Kennedy and Allworth, 2000). 
The National Animal Health Monitoring System (NAHMS) periodically 
evaluates producer attitudes and knowledge of JD as well as use of management 
practices related to herd biosecurity (NAHMS, 1994, 1999, 2010). An NAHMS study on 
beef in 1997 estimated that 92% of beef producers were either unaware of JD or only 
recognized the name (NAHMS, 1999) and this decreased to 69% in 2007-08 (NAHMS, 
2010). The United States Voluntary Bovine JD Control Program (VBJDCP) was created 
in 2002 to provide minimum national standards for the control of JD and to educate 
veterinarians and producers regarding management, prevention and control of JD 
(VBJDCP, 2002). Beef producers with herds having low-risk of JD (Level 4) in the US-
VBJDCP believe that a control program becomes economically beneficial as it 
progresses (Benjamin et al., 2009). A total of 59% of producers and 50% of veterinarians 
in Texas believed that losses in beef production due to JD are substantial (Benjamin et 
al., 2010). However, only 25% of producers with JD low-risk herds perceived a 
significant benefit of participation in control programs (Benjamin et al., 2009).  
 60 
 
Veterinarians presumably influence opinions of producers regarding the 
estimation of JD associated costs, testing and other control measures as veterinarians are 
often involved in educating their clients on JD (Benjamin et al., 2010). The purpose of 
this study was to describe and compare the perceptions of producers and veterinarians in 
terms of economic aspects of MAP infection in beef cow-calf herds using responses 
from mailed questionnaires.  
 
4.2 Materials and methods 
The study protocol was approved by the Institutional Review Board at Texas 
A&M University (protocol number 2010-06666).  
 
4.2.1 Questionnaire survey 
Questionnaire surveys were developed to investigate the perceptions of producers 
and veterinarians regarding the economic impact of burden of JD and appropriate control 
measures being carried out. A mailed questionnaire survey of beef producers who had 
risk assessments and herd management plans for JD were administered in nine US states 
(FL, GA, IA, MO, ND, SC, SD, WI, and WV). At the time of the survey, producers were 
either actively participating or had participated at one time in a JD control program. 
Another questionnaire was mailed to veterinarians from the same nine states with active 
membership in a nationwide professional organization and who listed “bovine” as one of 
their practice types. The majority of questions for the veterinarian and producer 
questionnaires were designed to be comparable.  
The Designated Johne’s Coordinators mailed the questionnaires to all beef 
producers that had JD risk assessments performed and herd management plans 
developed for JD. Veterinarians were contacted with an introductory letter 12 days prior 
to the mailing of questionnaires. A business reply envelope and a $2 bill were included 
in each questionnaire packet as an incentive to improve response proportions (Bhattarai 
and Fosgate, 2010). Reminder post-cards were mailed eight days after the questionnaire. 
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Additional details on questionnaire development and administration has been explained 
in Section 3.2.  
 
4.2.2 Analysis 
Responses from the completed questionnaires were recorded using SelectSurvey 
(ClassApps.com, 2006, SelectSurvey.NET 1.5.1) on a secure server located at the 
College of Veterinary Medicine and Biomedical Sciences, Texas A&M University. 
Unsolicited personal information revealed by some producers in free text comments 
were not recorded in the database. Data were downloaded and analyzed using Stata® 
version 11.2 (StataCorp., College Station, TX) and OpenEpi (Dean et al., 2011). 
Descriptive statistics were stratified by veterinarians and producers. Statistical analysis 
was performed with categories of respondents: veterinarians with and without JD 
certification, seedstock producers, commercial cow-calf producers, and producers with 
both seedstock and commercial cow-calf operations. Continuous outcomes were 
reported with the mean, minimum, median, and maximum, or median and inter-quartile 
range (IQR). Wilcoxon rank-sum tests were used to compare continuous variables that 
were not normally distributed based on the Shapiro–Wilk test. Associations between 
categorical exposures and outcomes were evaluated using chi-square tests. Beliefs 
concerning risks of disease and categorical responses related to economic metrics were 
evaluated among producers and veterinarians using odds ratios. Crude and adjusted odds 
ratios were calculated for different groups within cow-calf producers and veterinarians. 
Potential confounding was controlled by including herd-size, herd infection status 
(infected or uninfected), and the perception of the respondent whether veterinary 
expense is higher for infected cows in the statistical models. Herd size was categorized 
as small (<50 head), medium (50-149) or large (150 or more). Two-sided statistical tests 
were performed and results were interpreted at the 5% significance level. 
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4.2.2.1 Economic losses 
Survey data were used to estimate losses associated with MAP infected animals 
and predict overall herd-level monetary losses in typical cow-calf production scenarios. 
Pre-weaning losses were estimated using reduction in percent calving in infected cows 
and additional pre-weaning mortality of their calves. The loss in monetary terms was 
estimated based on the calf-crop at weaning and the prevailing price from the National 
Agricultural Statistics Service (USDA, 2012). Additional veterinary expenses for MAP 
infected cows reported by survey respondents were used as the loss due to additional 
cost of treating MAP infected cows. Total loss was the sum of component losses and 
reported in US$. 
 
4.2.2.2 Parameter estimates 
Triangular and beta distributions were used to model parameter inputs within the 
economic model (Table 11) using available software (@Risk, version 5.7, Palisade Corp, 
Ithaca, NY). Beta distribution parameters were estimated from survey data using 
available freeware BetaBuster (Su, 2006). Means and 95% credible regions (95% CR) 
were estimated for losses. Herd-level losses were projected to a cow-calf herd of 100 
cows with an mean seroprevalence of 3% (Roussel et al., 2005), which corresponds to a 
7% true prevalence after adjustment for the sensitivity and specificity of available serum 
ELISAs (Collins et al., 2006). Regression sensitivity analysis was conducted within 
@Risk by varying the value of each model input to estimate its impact on the total loss 
estimate. Sensitivity and robustness of models were evaluated using the relative values 




Table 11: Cow-calf producer and veterinarian parameter estimates used to estimate losses associated with 
Mycobacterium avium subspecies paratuberculosis infected beef cows 
 P Distribution 
Average (minimum, median, maximum) 
Producera Veterinariana 









15.5(2.3,9.7, 54.3) 14.6(0.9,9.4, 
85.5) 




1.7(0, 1, 15) 5.4(0, 5, 95) 
D Percent point increase in pre-weaning mortality in 





E Baseline weaning weight (kg, all cows) Triangular 258.8(35.4, 263.1, 351.5) 238.1(31.8, 
249.5, 362.9) 





12.45 (3.2, 10.26, 30.4) 11.36(0.83, 10, 
40) 
G Decrease in weaning weight in calves from infected 
cows E*F 
N Number of cows Fixed 100 100 
P Prevalence Fixed 7 7 
H Weaning weight per exposed female (uninfected) A*(1-C)*E 
I Weaning weight lost by average infected cow (A-B)*(1-C-D)*(E-G) 
J Weaning weight per cow adjusted for prevalence [(1-P)*A*(1-C)*E]+[P*(A-B)*(1-C-D)*(E-G)] 
K Decrease in total weaning weight per cow in herd H-J 
L US$ value of weaning weightc Triangular 2.7(2.4, 2.7, 3.1) 2.7(2.4, 2.7, 3.1) 
M Value of decrease in WW in infected herds K*L 
R Increased veterinary costs in infected herds cow Triangular 33.4(0,22.5,100) 31.8(1,20,250) 
a Producers estimated values in their own herds while veterinarians estimated values from client herds 
b P denotes producers and V denotes veterinarians. Corresponding values in parenthesis were the parameters used in beta distribution. Proportions based on percentages reported in the 
table were used to estimate beta distribution parameters. 




4.3.1 Description of respondents 
Responses were received from160 of 989 (16%) contacted producers provided 
responses. The average (minimum, median, maximum) herd size was 155 head (1, 70, 
2500). A total of 41% (66/160) of producers had only commercial cow-calf herds, 40% 
(60/160) had only seedstock and 19% (30/160) had both cattle types. All producers were 
considered to have participated in a control program at one point since they had 
completed a JD risk assessment or management plan in the past. A total of 95% 
(149/157) of producers had tested their herds at least once and 74% (117/158) were 
enrolled in a control program at the time of survey.  
Of 1,080 questionnaires sent to veterinarians, 325 (30%) were completed and 
returned. A total of 41% (132/325) of veterinarians reported that they had been JD 
certified. Unregistered cow-calf operations were the most frequent type of clients (85%, 
275/325) followed by registered commercial cow-calf (69%, 224/325), registered 
seedstock (58%, 189/325), and unregistered seedstock operations (32%, 107/325). There 
were veterinarians with other client types including feedlot (57%, 184/325) as well as 




Table 12: Comparison of producer estimates for their own herds and veterinarian 
estimates for client cow-calf herds  
Variables Producers Veterinarians Pa 
Herd Productivity (all cows): Average (min, median, max)   
Calving percentage 95.3 (70, 95, 100) 89.96 (10, 90, 100) <0.001 
Pre-weaning calf mortality 
percentage  
1.7 (0, 1, 15) 5.36 (1, 5, 95) 
<0.001 
Weaning weight of calves, kg 259 (35, 263, 352) 238 (32, 250, 363) <0.001 
Productivity lost due to MAP infection: Average (min, median, max) 
Percent decrease in calving  15 (2, 10, 54) 14.5 (1, 9, 86) 0.588 
Percent increase in calf mortality  23.5 (1,20,50) 16.3 (0.5,10,75) 0.243 
Lost weaning weight, kg 30.9 (9.1, 22.7, 79.4) 26.6 (2.3, 22.7, 90.7) 0.098 
Expenses: Average (min, median, max)   
US$ veterinary expense per cow 31.8 (0, 21, 150) 27.2 (2, 20, 200) 0.495 
Additional veterinary expense per 
infected cow 33.4 (0, 22.5, 100) 31.8 (1, 20, 250) 0.465 
Percent income lost due to presence 
of JD infected cattle in herd 
3.24 (0, 0, 30) 7.19 (0, 5, 40) <0.001 
a P values based on Wilcoxon rank-sum 
 
 
4.3.2 Economic metrics 
Baseline calving percentage and weaning weight of calves were reported to be 
higher (P<0.001) by producers (Table 12). However, producers reported a lower pre-
weaning calf mortality percentage (P<0.001). Income lost due to the presence of JD in 
an infected herd was perceived to be higher by veterinarians (P<0.001). Compared to 
veterinarians without JD certification, seedstock producers were six times more likely 
(P=0.002) to agree that there is genetic loss due to culling cows positive for MAP (Table 
13). Seedstock producers were less likely to believe MAP infected dams wean lighter 
calves (P=0.006) or have higher pre-weaning mortality (P=0.020). 
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Table 13: Comparison of polar questions about economic metrics associated with Mycobacterium avium subspecies 
paratuberculosis infected herds reported by cow-calf producers and veterinarians  
Respondent type Crude odds ratio Adjusted odds ratioa 
Calving percentage is lower OR (95% CI)   P OR (95% CI) P 
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 0.97 (0.54 to 1.77) 0.931 1.17 (0.58 to 2.37) 0.657 
Producers with seedstock only 0.56 (0.23 to 1.39) 0.210 0.43 (0.14 to 1.28) 0.132 
Producers with commercial cow-calf only 0.51 (0.21 to 1.25) 0.142 0.56 (0.20 to 1.64) 0.293 
Producers with both seedstock and commercial cow-calf 0.43 (0.12 to 1.49) 0.183 0.29 (0.06 to 1.51) 0.142 
Higher pre-weaning mortality     
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 0.78 (0.43 to 1.42) 0.422 0.79 (0.40 to 1.58) 0.504 
Producers with seedstock only 0.31 (0.11 to 0.85) 0.023 0.22 (0.06 to 0.79) 0.020 
Producers with commercial cow-calf only 0.71 (0.30 to 1.67) 0.434 0.67 (0.25 to 1. 82) 0.436 
Producers with both seedstock and commercial cow-calf 0.97 (0.31 to 3.06) 0.957 0.37 (0.08 to 1.81) 0.223 
Lower average weaning weight     
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 0.85 (0.35 to 2.04) 0.709 1.08 (0.40 to 2.94) 0.876 
Producers with seedstock only 0.21 (0.77 to 0.58) 0.002 0.19 (0.06 to 0.62) 0.006 
Producers with commercial cow-calf only 0.66 (0.21 to 2.01) 0.460 0.58 (0.15 to 2.24) 0.427 
Producers with both seedstock and commercial cow-calfb - - - - 
a Adjusted for herd-size, infection status, and the perception of the respondent whether veterinary expense is higher for infected cows 
b No response in this category
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Table 13 Continued 
Respondent type Crude odds ratio Adjusted odds ratioa 
Genetic loss OR (95% CI)   P OR (95% CI) P 
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 1.07 (0.62 to 1.84) 0.811 1.07 (0.56 to 2.04) 0.832 
Producers with seedstock only 5.00 (1.97 to 12.67) 0.001 6.15 (1.92 to 19.65) 0.002 
Producers with commercial cow-calf only 1.02 (0.50 to 2.07) 0.960 1.66 (0.64 to 4.23) 0.291 
Producers with both seedstock and commercial cow-calf 0.98 (0.41 to 2.36) 0.973 2.29 (0.58 to 8.96) 0.235 
Higher veterinary expenses     
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 0.75 (0.42 to 1.33) 0.325 0.76 (0.43 to 1.36) 0.358 
Producers with seedstock only 0.90 (0.38 to 2.12) 0.810 1.00 (0.41 to 2.46) 0.996 
Producers with commercial cow-calf only 0.81 (0.37 to 1.77) 0.595 0.79 (0.34 to 1.81) 0.582 
Producers with both seedstock and commercial cow-calf 5.00 (0.62 to 40.41) 0.131 5.45 (0.66 to 45.05) 0.115 
a Adjusted for herd-size, infection status, and the perception of the respondent whether veterinary expense is higher for infected cows 
b No response in this category
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Table 14: Estimates of economic metrics in beef cow-calf herds in presence and 
absence of Mycobacterium avium subspecis paratuberculosis (MAP) infection by 
cow-calf producers and veterinarians 
Respondent type n Median (IQRa)  P 
Lowered percentage of calving by MAP infected cows    
Veterinarians without JD certification (reference) 72 10 (9.25, 20)  
Veterinarians with JD certification 58 10 (7.5, 20) 0.958 
Producers with seedstock only 5 10(5, 20) 0.702 
Producers with commercial cow-calf only 10 10(5, 30) 0.833 
Producers with both seedstock and commercial cow-calf 5 10 (10, 15) 0.992 
Higher percentage of pre weaning mortality risk in 
calves from MAP infected dam 
  
 
Veterinarians without JD certification (reference) 61 10 (7.5, 20)  
Veterinarians with JD certification 35 10 (5, 20) 0.522 
Producers with seedstock only 1 10 0.819 
Producers with commercial cow-calf only 7 25 (10, 50) 0.076 
Producers with both seedstock and commercial cow-calf 5 10 (5, 20) 0.738 




Veterinarians without JD certification (reference) 97 23 (20, 34)  
Veterinarians with JD certification 57 23 (23, 34) 0.997 
Producers with seedstock only 8 23 (20, 40) 0.660 
Producers with commercial cow-calf only 22 24 (23, 45) 0.040 
Producers with both seedstock and commercial cow-calf 9 23 (35, 32) 0.864 




Veterinarians without JD certification (reference) 78 20 (10, 50)  
Veterinarians with JD certification 39 15 (10, 30) 0.065 
Producers with seedstock only 10 22.5 (10, 50) 0.932 
Producers with commercial cow-calf only 15 20 (10, 50) 0.563 
Producers with both seedstock and commercial cow-calf 5 50 (40, 100) 0.104 
Percentage of income lost due to presence of MAP 
infected cattle in herd 
  
 
Veterinarians without JD certification (reference) 130 5 (2, 10)  
Veterinarians with JD certification 86 5 (3, 10) 0.717 
Producers with seedstock only 37 0 (0, 0.1) <0.001 
Producers with commercial cow-calf only 44 3 (0, 10) 0.004 
Producers with both seedstock and commercial cow-calf 1 0 (0, 0) <0.001 
a Interquartile Range 
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Perceptions concerning JD-related economic metrics were generally not 
significantly different among respondent categories (Table 14). However, commercial 
cow-calf producers perceived a larger negative impact on weaning weight relative to 
veterinarians without JD certification (P=0.040). All producer categories reported a 
higher percentage of herd income lost due to presence of MAP infected cattle in a herd 
compared to veterinarians without JD certification (P0.004). 
 
4.3.3 Risk of diseases / conditions 
Compared to the reference category of veterinarians without JD certification, the 
perceived odds of lameness in MAP infected cattle were higher for producers with both 
seedstock and commercial cow-calf operations (P=0.021) (Table 15). Odds of neurologic 
diseases in MAP infected cattle were perceived to be lower by veterinarians with JD 
certification compared to those without (P=0.017). Producers with commercial cow-calf 
herds perceived four times higher odds of neurological disease (P=0.008) based on the 
crude model, but the association was not significant after adjustment for potential 
confounders. In general, perceptions of JD certified veterinarians and other producer 






Table 15: Comparison of perceptions about higher risk of diseases and conditions in Mycobacterium avium subspecies 
paratuberculosis infected cows reported by cow-calf producers and veterinarians 
 Odds Ratios (OR) 
Respondent type Crude Adjusteda 
Mastitis OR (95% CI) P OR (95% CI) P 
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 1.11 (0.63 to 1.97) 0.711 0.99 (0.49 to 2.00) 0.985 
Producers with seedstock only 0.28 (0.07 to 1.07) 0.063 0.31 (0.07 to 1.34) 0.120 
Producers with commercial cow-calf only 0.31 (0.11 to 0.89) 0.029 0.29 (0.07 to 1.25) 0.098 
Producers with both seedstock and commercial cow-calf 0.26 (0.05 to 1.28) 0.097 0.16 (0.02 to 1.53) 0.112 
Pneumonia     
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 1.22 (0.67 to 2.20) 0.520  1.18 (0.58 to 2.44) 0.639 
Producers with seedstock only 0.78 (0.30 to 2.04) 0.618  0.69 (0.21 to 2.24) 0.539 
Producers with commercial cow-calf only 1.15 (0.46 to 2.83) 0.769  1.68 (0.46 to 6.13) 0.426 
Producers with both seedstock and commercial cow-calf 1.21 (0.36 to 4.08) 0.763  0.96 (0.15 to 5.93) 0.962 
Lameness     
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 1.93 (1.05 to 3.54) 0.033 2.07 (0.96 to 4.43) 0.063 
Producers with seedstock only 1.63 (0.50 to 5.38) 0.420 2.68 (0.67 to 10.73) 0.162 
Producers with commercial cow-calf only 1.49 (0.57 to 3.91) 0.414 1.12 (0.25 to 5.01) 0.874 
Producers with both seedstock and commercial cow-calf 4.18 (1.27 to 13.76) 0.019 8.30 (1.37 to 50.10) 0.021 
Dystocia     
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 1.00 (0.55 to 1.82) 0.993 1.29 (0.64 to 2.60) 0.469 
Producers with seedstock only 1.47 (0.52 to 4.17) 0.465 1.39 (0.43 to 4.57) 0.580 
Producers with commercial cow-calf only 1.90 (0.81 to 4.66) 0.136 1.77 (0.56 to 5.62) 0.333 





Table 15 Continued 
 Odds Ratios (OR) 
Respondent type Crude Adjusteda 
Grass tetany OR (95% CI) P OR (95% CI) P 
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 0.61 (0.28 to 1.32) 0.208  0.57 (0.22 to 1.44) 0.230 
Producers with seedstock only 1.77 (0.55 to 5.76) 0.341  1.81 (0.43 to 7.60) 0.415 
Producers with commercial cow-calf only 2.05 (0.80 to 5.29) 0.136  1.57 (0.43 to 5.68) 0.494 
Producers with both seedstock and commercial cow-calf 3.72 (1.15 to 12.07) 0.028  1.98 (0.36 to 10.76) 0.430 
Neurologic diseases     
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 0.39 (0.18 to 0.86) 0.020 0.31 (0.11 to 0.81) 0.017 
Producers with seedstock only 2.02 (0.68 to 6.05) 0.207 1.13 (0.27 to 4.73) 0.870 
Producers with commercial cow-calf only 3.76 (1.42 to 9.94) 0.008 3.56 (0.85 to 14.95) 0.083 
Producers with both seedstock and commercial cow-calf 1.16 (0.32 to 4.12) 0.823 0.49 (0.08 to 2.93) 0.435 
Non-diarrheal digestive diseases     
Veterinarians without JD certification (reference)     
Veterinarians with JD certification 0.64 (0.34 to 1.21) 0.170  0.55 (0.26 to 1.19) 0.133 
Producers with seedstock only 0.57 (0.21 to 1.54) 0.268  0.40 (0.12 to 1.27) 0.120 
Producers with commercial cow-calf only 1.45 (0.51 to 4.12) 0.486  6.98 (0.83 to 58.46) 0.073 
Producers with both seedstock and commercial cow-calf 1.08 (0.29 to 4.09) 0.906  0.30 (0.06 to 1.46) 0.136 







4.3.4 Predicted losses  
An annual loss of $235 (95% CR: $89 to $457) for each infected animal was 
estimated based on information from the producer survey (Figure 3). The analogous 
estimate using information collected from veterinarians was $250 ($82 to $486). 
Lowered weaning weight of calves from infected cows alone contributed an average of 
$87 ($28 to $213) or 40% (27 to 47%) of total loss per infected cow based on the data 





Figure 3. Mean (bar) and 95% credibility regions (whiskers) for estimated annual 
herd level losses in a 100 cow MAP infected beef herd at a prevalence of 7% 





Annual average loss in a 100 cow herd at 7% true prevalence for MAP was 
$1,644 (95% CR: $625 to $3,250) based on the information collected from the 
producers. Estimated average annual loss was $1,747 ($575 to $3,375) based on data 




calving proportion from an infected cow (regression coefficient, b = 0.68), baseline 
weaning weight (b = 0.63), and increased veterinary cost for infected cow (b = -0.23) 
were the most influential inputs for herd level losses based on the producer survey. 
Similarly, percent decrease in calving proportion from an infected cow (b =0.61), 
increased veterinary costs for infected cows (b = 0.55), and baseline weaning weight of 
calves (b = 0.49) were the most influential factors based on veterinarian survey data.  
 
4.4 Discussion 
Producers and veterinarians both perceived losses associated with JD in beef 
cow-calf operations due to lowered production and additional expenses. There were 
some differences in perceptions between producers and veterinarians regarding losses 
due to reduced calving proportions, higher calf mortality, lower weaning weight and 
higher veterinary expenses. The effects of JD within beef cattle may cause premature 
culling of affected animals, decreased milk production reducing the weaning weights of 
calves, reduced body weight of culled animals and loss of potential markets (Roussel, 
2011). Some of these losses are analogous to MAP infected dairy herds having higher 
replacement costs (Johnson-Ifearulundu et al., 1999), lower milk production and 
additional feed costs (Ott et al., 1999; Raizman et al., 2009). Affected cows have higher 
mortality and there is a decrease in the weight of cows that are culled (Johnson-
Ifearulundu et al., 1999). Subclinical MAP infection contributes to a decrease in total 
milk, fat, and protein over the lactation and a shorter productive lifespan (Gonda et al., 
2007). Subclinical cows also have reduced fertility (Johnson-Ifearulundu et al., 2000) 
and receive lower slaughter prices (Benedictus et al., 1987) usually due to a decrease in 
the weight of cull cows (Johnson-Ifearulundu et al., 1999). 
Between 0.4% and 9% of seropositive cows are estimated to be present in 8% to 
63% of US beef herds (Thorne and Hardin, 1997; NAHMS, 1999; Dargatz et al., 2001; 
Hill et al., 2003; Roussel et al., 2005). Compared to veterinarians without JD 
certification, certified veterinarians and all classes of producers were generally less 




weaning weight of calves born to MAP infected cows. Commercial cow-calf producers 
perceived significantly lower weaning weights of calves by MAP infected cows. The 
magnitude of production related metrics reported by different producer classes were 
generally similar to veterinarians without JD certification. In spite of the differences in 
estimated medians, significant differences were not observed in some of the comparisons 
mainly due to low number of responses. Nevertheless, producers perceived significantly 
lower percentage of income lost due to MAP presence within the herd. 
Lameness, pneumonia and mastitis have been reported to be the most common 
clinical diseases among fecal culture positive dairy cows in specific herds (Raizman et 
al., 2007). Except for mastitis, JD certified veterinarians and all producer classes were 
generally more likely to perceive higher risks of diseases and conditions in MAP 
infected cows. This is analogous to the perception that there is additional veterinary 
expense per infected cow. Significant differences were also observed as JD certified 
veterinarians perceived higher risk of lameness but lower risk of neurological diseases 
compared to non-certified veterinarians. Increased incidence of diseases and conditions 
in MAP infected cattle is a possible reason for the additional cost of treatment reported 
by 68% of producers and 64% of veterinarians. However, the perceived magnitude of 
losses varied among respondent classes. One of the reasons for mixed opinions is due to 
different burden of MAP infection in the respondent producer herds leading to a 
different degree of experience related to diseases and conditions. Another reason could 
be the higher premium of cows owned by seedstock producers, which is much different 
from commercial cow-calf producers. 
Compared to the reference category of veterinarians without JD certification, 
seedstock producers were five times more likely to perceive a genetic loss when MAP 
infected cows are culled. This relates to the primary purpose of seedstock operations to 
improve the genetic value of their animals. While seedstock producers are more 
concerned about genetic determinants of production (weaning weight), commercial cow-
calf producers are more concerned about the absolute weaning-weight loss because price 




The perceived average loss in weaning weight of 31 kg and 27 kg by producers and 
veterinarians, respectively was fairly close to 27 kg lower weaning weight of calves 
from fecal culture positive beef cows (Bhattarai et al., 2013). 
 Return over total costs was negative for cow-calf producers during ten of the 
years between 1972 and 1989 (Krause, 1992) and for 26 of the 30 years between 1979 
and 2008 in Kansas (Pope et al., 2011). This reflects, in part, the contribution of beef 
producers that choose to raise cattle for reasons other than as a primary source of 
income. Beef producers might be less concerned about the impact of JD due to a 
presumably lower within herd prevalence compared to dairy producers and lack of 
records to determine the true economic impact (Roussel, 2011). Of beef producers with 
Level 4 herds in the VBJDCP, 75% did not realize a significant benefit or realized only a 
marginal benefit from participation in the VBJDCP (Benjamin et al., 2009). However, 
dairy producers appear somewhat more concerned about the impact of JD. Level 3 and 4 
(low-risk) dairy producers in the VBJDCP believed it was an economically beneficial 
strategy (Kovich et al., 2006). However, in a study of 40 dairies actively working to 
control JD on their operations, 15 (38%) producers perceived financial benefit while 
only five (13%) producers perceived an actual increase in revenue (Groenendaal and 
Wolf, 2008). In a previous study, 64% of veterinarians had educated beef producers on 
management strategies for the control or elimination of JD, but only 36% of 
veterinarians had received specific training regarding JD and 29% were JD-certified 
(Benjamin et al., 2010). In Canada, veterinarians had positive attitudes towards training 
for the prevention and control of JD and the majority also thought that training should be 
completed every few years (Sorge et al., 2010). 
A limitation of this study was only selecting producers who had risk assessment 
and herd management plans from a subset of US states. These producers are therefore 
more likely than a typical producer to perceive benefits because they had voluntarily 
enrolled to control JD. Estimates of the effects of JD would have likely been different 
from a randomly selected population that had not been involved in a JD control program. 




despite the assurance that researchers would not collect any identifying information. A 
further limitation was the inability to evaluate whether responses varied by the 
geographic location of respondents. Important sources of losses are expected to vary by 
producer types and this was evidenced by the observation that only seedstock producers 
were concerned about the loss of valuable genetics. For the evaluation of perceived 
losses, most questions concerned directly measurable losses. Miscellaneous indirect 
costs could be substantial but are difficult to perceive. More comprehensive methods 
such as standardized performance analysis are necessary to account for all losses. Such 
estimates can account for different herd sizes, feeding practices, real estate, machinery, 
breeding stock investments, calving percentage, death loss and breeding-season length. 
Management-related costs are important to estimate profit in cow-calf herds. Awareness 
of the producers on the need of maintaining proper financial records is important to 
obtain such information inputs for accurate analysis. The herd level losses might have 
been underestimated using the 7% true prevalence derived from 3% seroprevalence 
(Roussel et al., 2005) because there are also reports of 5% (Thorne and Hardin, 1997), 
and 9% seroprevalence (Hill et al., 2003) in beef herds in other US states. Higher 
premium for animals was not accounted for in the analysis and this, can be substantial 





5. HERD-LEVEL ECONOMICS OF CULLING DECISIONS BASED ON 
MICROBIOLOGICAL AND SEROLOGICAL TEST RESULTS FOR JOHNE’S 
DISEASE IN BEEF COW-CALF OPERATIONS 
 
5.1 Introduction 
Johne’s disease (JD) in cattle is a chronic and slowly progressing disease caused 
by infection with Mycobacterium avium subspecies paratuberculosis (MAP) that causes 
considerable production losses (Sweeney, 1996; Harris and Barletta, 2001; Manning and 
Collins, 2001). Economic losses in beef herds occur due to lower weaning weight of 
calves (Bhattarai et al., 2013), premature culling of affected animals, reduced body 
weight of culled animals and loss of potential markets (Roussel, 2011). The prevalence 
of JD in specific beef herds could be as high as 28% based on adjustment for sensitivity 
and specificity (Collins et al., 2006) of reported seroprevalence (Thorne and Hardin, 
1997; Hill et al., 2003; Pence et al., 2003; Roussel et al., 2005). While the effectiveness 
of JD control measures are largely unknown, a voluntary JD control program was 
implemented in the US on 66 dairy herds and 22 beef herds in 17 states (Fossler, 2007). 
The participation of beef herds was considered to be low compared to dairy herds (Wells 
et al., 2008; Benjamin et al., 2010).  
The majority of US beef producers as well as veterinarians and other 
stakeholders are unaware about the losses associated with JD. Despite being low overall, 
the percentage of beef producers who perceived a loss due to JD increased from 12% in 
1994 (NAHMS, 1994) to 38% in 2010 (NAHMS, 2010). The economic impact of 
chronic diseases is typically greatest during the sub-clinical phase suggesting that early 
interventions may provide a higher return on investment due to increased production 
efficiency (Marsh, 1999). There is no mandatory JD control program in the US and herd 
level control is a choice that must be made by producers based on perceived benefits, 
economic or otherwise  
Decision support systems are computer-based approaches that employ existing 
data and knowledge to facilitate decision making (Power and Sharda, 2009). Decision 




program. Models estimating losses and benefits associated with specific management 
alternatives to control JD have been developed for dairy cattle (Collins and Morgan, 
1991; Collins and Morgan, 1992; Dorshorst et al., 2006). Studies evaluating the 
economic aspect of JD control strategies in beef cow-calf herds are limited. A 
deterministic cost-benefit model reported that improved management was able to reduce 
the prevalence but test and cull programs were not cost-effective (Bennett et al., 2010). 
Control rather than eradication was also identified as the preferred option for many 
commercial beef herds because eradication was only profitable in the longer term when 
discounts on the sale of stock from infected herds was high (Webb Ware et al., 2012). 
Factors that must be considered when evaluating the benefit of JD control 
include reduced calving proportion, increased pre-weaning mortality, and lower weight 
of calves and cull cows among the infected stock. The objective of the present study was 
to compare the benefits of JD control for the scenarios of no-testing, serum ELISA 
testing, bacterial culture of feces (BCF) testing, and ELISA screening with BCF 
confirmation (EBCF) in an infected beef cow-calf herd using a decision tree model. A 
secondary objective was to estimate benefits over multiple years as MAP prevalence is 
reduced through the yearly test and cull with replacements obtained from low-risk herds. 
 
5.2 Materials and methods 
5.2.1 Data sources 
The economic model was constructed using inputs from multiple sources (Table 
16). Inputs for cow and herd level productivity were based on data obtained from a 
survey of beef cow-calf producers (Bhattarai et al., 2012) and presented in Sections 3 
and 4 of this dissertation. Test costs were obtained from a paratuberculosis testing 
laboratory (TVMDL, 2013) and commodity values were based on 2012 statistics 
(USDA, 2012), and published reports (Apple, 1999). The effect on weaning weight of 
calves from infected cows was estimated from beef herds enrolled in a US national 
control program. Test sensitivity and specificity estimates were obtained from a 




Table 16: Decision tree analysis inputs for JD control in a US cow-calf operation 
involved in a test and cull program 
 Input Distribution Values / parameters 
 Fecal culture: sensitivity Beta (162.65,108.77)a 
 Fecal culture: specificity Beta (5752.3,6.8)a 
 Serum ELISA: sensitivity Beta (60.7,140.4)a 
 Serum ELISA: specificity Beta (560.7,6.6)a 
P True prevalence 0 to 100% with 1% increment  
 
ELISA test cost  ($) 





W Live weight of cull cow (kg)  Normal (481.1, 50.9)c 
A Value of test-negative replacement cow ($) Triangular  1643 (1257 to 1833)d 
U Value of replacement from unknown herd ($) Uniform (A-389.85, A-371.42)e 
L Additional cost for low-risk replacement ($) A-U  
B Value of test-positive cull cow ($) Uniform W*(1.98, 1.92)f 
C Cull and replace cost ($) A-B 
 Cull and replace cost – adjusted ($) L*V + C*(1-V) 
V Voluntary annual culling proportion Beta (3.9, 27.4) e 
D Calving proportion in non-infected cows Beta (36.7, 2.9) e 
E Calving proportion in infected cows Beta D- (1.3, 5.7) e 
F Price per kg calf ($) Triangular 2.68 (2.38 to 3.13)g 
K Weaning weight: fecal culture negative (kg) Normal (249.8, 35.3)h 
L 
Kg lost per calf from test-positive dam: fecal 
culture positive 
Normal (33.26, 7.30)h 
M 
Additional pre-weaning mortality proportion in 
calves from infected cows 
Beta (1.03 , 33.12)e 
Q 
Lowered calving proportion in MAP infected 
cows 
Beta (1.3,5.7)e 
R Additional treatment cost for infected cows ($) Triangular 22.5 (10 to 50)e 
S Adjusted weight lost per calf: fecal culture (kg) L+(M/100)*(K-L)+(Q/100)*K 
T Price received by calf from uninfected cow ($) K*F  
U 
Cost due to lost weight, calf mortality and lower 
calving ($) 
F*S  
 Price received by calf from infected dam ($) T-U  
a Collins et al. (2006)  
b Texas Vet. Med. Diag. Laboratory data 
c Cull cow at BCS 5 (Apple, 1999)  
d 1-3 year female cattle (Meek et al., 1999), adjusted for 
2012 cow-calf price (index = 1.6 times that of 1999)  
 
e Survey of producers (Bhattarai et al., 2012) 
f NASS: Cattle (excluding calves), price 
received, Kg 
g NASS; Cattle, calves – price received, Kg  






Model costs and the prices received for farm commodities include some 
important assumptions. A herd going through a test-based control program is assumed to 
get replacements from low-risk herds (Voluntary Bovine Johne’s Disease Control 
Program, VBJDCP, Level 4 or higher herds with 1% or less infected cows), which are 
more expensive than a replacement from a herd of unknown JD status (Bhattarai et al., 
2012). A non-testing herd is assumed to purchase less expensive replacements from 
herds of unknown JD status. Price received for a weaned calf was based on the weight of 
an average weaned calf (Bhattarai et al., 2013). Losses associated with an infected dam 
were attributed to reduced calving proportion, higher pre-weaning mortality, and lower 
weaning weight of calves. Cost of testing was estimated using standard laboratory fees 
with an estimated additional $5 labor cost per animal. Costs associated with treatment of 
infected cows (for other conditions at higher incidence in MAP infected cows) and cost 
of culling and replacement were also included. Additional details on steps used to 
calculate the model inputs have been presented in Appendix C. 
 
5.2.2 Decision tree 
A decision tree model was constructed within MS-Excel (Microsoft Corporation, 
Redmond, WA, version 2010) using Precision Tree (Palisade Corporation, Ithaca, NY, 
version 5.7). Decision trees provide a graphical structure of hierarchically linked 
decisions and chance events (Figure 4). The first node of the constructed tree was the 
producer’s decision of whether or not to test all adult breeding cows (over two years of 
age) in the herd. The testing decision was structured to branch further into selection of 
test type: ELISA, BCF, or EBCF. Conditional probabilities for each branch of the 
chance (probability) node were calculated based on sensitivities, specificities and 
prevalence. Chance nodes were included for true infection status, test results, culling, 
and calving outcomes. Priority for voluntary culls was given to test-positive cows. 
Additional culls were obtained from test-negatives when test positive percentage was 
less than the voluntary culling percentage. All replacements for a tested herd were 




and infected calves varied based on lower calving probability and higher pre-weaning 




Figure 4. Decision tree for the economical evaluation of testing options for the 
control of Mycobacterium avium subspecies paratuberculosis in beef cow-calf herds.  





The value of a specific decision branch is the probability-weighted average value 
of all corresponding terminal nodes. The economically prudent decision is the no-test, 
ELISA, BCF or EBCF decision option with the highest return (or lowest cost, benefit-
cost) evaluated for each possible level of prevalence between 0 to 100% at a 1% 





Figure 5: Test and cull with replacement cycle for the control of Mycobacterium 
avium subspecies paratuberculosis in beef cow-calf operations 
 
 
5.2.3 Multi-year evaluation  
An independent spreadsheet model was developed to estimate yearly changes in 
herd prevalence after implementation of a test and cull program (Figure 5). Spreadsheet 
assumptions included all test-positive cows being culled and replaced with cows from 




herds for both testing and non-testing herds.  All culls were assumed to be from test 
positives and the native herd stock allowing purchased low-risk replacements from 
earlier years to remain in the herd. There was a probability of 1% that replacements were 
infected with MAP, but within herd transmission was considered zero due to the sale of 
all weaned calves. The herd was assumed to have 100 cows with an initial true 
prevalence of 10%. Total yearly costs and cumulative costs over the control program 
were estimated based on test costs and production losses due to MAP infection. 
Uncertainties associated with outcomes were modeled using the stochastic probability 
distributions described for the single year evaluation. Farm costs based on no-test, 
testing with ELISA, testing with BCF, and testing with EBCF annually were calculated 
until the true herd prevalence was reduced to 0.5% (<1 infected animal in a 100 cow 
herd). 
 
5.2.4 Sensitivity analysis 
A regression sensitivity analysis was conducted using @Risk. The software 
varies the value of each model input and determines its regression coefficient for 
predicting return for each test decision branch. Critical variables for each decision were 
identified and ranked based on the relative values of regression coefficients. The most 
influential parameters contributing to total cost of MAP control in the multi-year test and 




Table 17: Parameters and algorithm used to estimate yearly costs of MAP in a herd 
under test-based culling  
  Input variables Distribution and inputsa 
N Noumber of adult cows in herd 100 cows (for illustration) 
P Estimated number of infected cows 10 (initial 10% true prevalence) 
 Test choice: ELISA, BCF or EBCFb Choice of the producer 
AP No. of test positive cows 
Based on sensitivity and 
specificity of chosen test 
(Collins et al., 2006) 
A Average weaning weight (kg) Normal(249.8, 35.3) 
B 
Lowered weaning weight of calf from 
infected cow (kg) 
Normal(33.26, 7.3) 
C Calving proportion Beta(36.7,2.88) 
D Pre weaning mortality proportion Beta(1.35,70.911) 
E Weaning proportion C-D 
F Additional pre-weaning mortality – infected Beta(1.03 , 33.1) 
G Lowered calving proportion - infected Beta (1.3,5.7) 
H 




Total calf crop weaning weight assuming all 
cattle are test negative (kg) 
A*E*N 
J 
Total weaning weight adjusting for infected 
stock (kg) 
I-(A-B)*P*H 
L Lost weaning weight (kg) I-J 
K Annual average price per kg weaned calf ($) $2.73 
KL 
Lost weaning weight revenue over the year 
($) 
K*L 
R Annual average replacement cost per cow ($) Triangular (1257, 1643, 1833) 
AP 




Average market price of a cull cow 
(received) ($) 
NASS, from Table 16 
S Additional replacement costs ($) (R-M)*AP 
T 
Average market price of a sick cow (culled 
due to Johne's disease) ($) 
M*0.9 (10% lower weight) 
U Loss due to the cull being test positive ($) M-T 
X Lost revenue due to test positive culls ($) AP*U 
Y Additional treatment cost for infected ($) Triangular(0,22.5,100)*P 
Z Total yearly test and labor cost 16.6 (ELISA); $23 (BCF) 
 Total annual cost ($) KL+S+X+Y+Z 
a Derived from the inputs described in Table 16 





5.3.1 Herds testing for the first time 
Herd-level returns decreased with increasing MAP prevalence when the herd was 
not tested (Figure 6). The annual return was lower for all testing options compared to no 
testing within the simulated beef herd with a regular culling and replacement cycle. The 
additional cost incurred for obtaining low-risk replacements was higher than the 
potential return recoverable by eliminating costs due to JD in the herd. Recovery of 
losses after the test based culling of an infected dam was highest at a true prevalence of 
23% for BCF, 40% for ELISA and 70% for EBCF. Maximum returns at these thresholds 
were $374.9 (95% CR; -27.9 to 580.6) for BCF, $339 (95% CR -72.45 to 536.85) for 





Figure 6: Average cow level return at different levels of prevalence based on tests for 
Mycobacterium avium subspecies paratuberculosis in beef cow-calf herds. Estimated 
based on the following options: no-test (dotted line), ELISA (solid line), bacterial culture 
of feces (long dash), and ELISA screening followed by bacterial culture of feces 




5.3.2 Multi-year testing. 
Culling BCF-positives and replacing with low-risk heifers annually caused a 
faster rate of reduction in herd prevalence compared to culling decisions based on 
ELISA alone or EBCF (Figure 7). A herd with 10% prevalence conducting a test and cull 
program based on BCF achieved a prevalence of less than 0.5% in five years while it 
took 11 years to reach the same prevalence with an ELISA-based control program and 
18 years with EBCF-based control program. The median cumulative cost of MAP 
infection per cow until prevalence was reduced to less than 0.5% was $1,069 (95% CR: 
505 to 2,241) for the ELISA-based control program, $548 (95% CR: 286 to 1,164) for 
the BCF-based control program, and $1,774 (95% CR: 880 to 3,648) for the EBCF-
based control program. The prevalence in untested herds was 5% and the cumulative 
median cost was $1839 (95% CR: 932 to 3,807) after 20 years of obtaining replacements 




Figure 7: Prevalence changes after introduction of test based culling in a beef cow-
calf herd with 10% initial prevalence of Mycobacterium avium subspecies 
paratuberculosis. Estimated based on the following options: no-test (dotted line), 
ELISA (solid line), bacterial culture of feces (long dash), and ELISA screening 




Costs associated with MAP infected cows were highest in the first year and 




Figure 8: Cost changes after introduction of test based culling in a beef cow-calf 
herd with 10% initial prevalence of Mycobacterium avium subspecies 
paratuberculosis. Estimated based on the following options: no-test (dotted line), 
ELISA (solid line), bacterial culture of feces (long dash), and ELISA screening followed 
by bacterial culture of feces confirmation (short dash). 
 
 
5.3.3 Sensitivity analysis  
The most influential inputs on the value of the ELISA decision were the price of 
a low-risk replacement cow (b = -0.67), price of a replacement cow from a herd of 
unknown JD status (b = 0.55), and the voluntary culling rate (b = -0.38). The BCF 
decision was most sensitive to true prevalence (b=-0.30), weaning weight of a calf from 




EBCF decision was most sensitive to the true prevalence (b=0.67), price of a low-risk 
replacement (b=-0.58), and the price of a replacement from a herd of unknown JD status 
(b=0.46).   
The most important factors for the cumulative cost were the voluntary culling 
rate, price of a low-risk replacement and the weight of a cull cow for all testing and not-
testing options. Regression coefficients for the voluntary culling rate for ELISA, BCF, 
EBCF and no-test were 0.85, 0.87, 0.85 and 0.83, respectively. Regression coefficients 
for the price of low-risk replacement were 0.35, 0.35, 0.35, and 0.39, respectively. 
Similarly, weight of a cull cow was the third most influential factor with regression 




JD control in the US is voluntary and the primary reason is to improve herd 
productivity through reducing disease prevalence. The current study compared the 
benefits under the scenarios of no-testing, serum ELISA testing, BCF testing, or EBCF 
testing in an infected beef cow-calf herd. The decision tree modeled return after a single 
MAP test and culling cycle with purchased replacements from low-risk herds. The long 
term effect on MAP prevalence and MAP associated costs were also estimated. Total 
production decreased linearly with increasing prevalence. Compared to ELISA and 
EBCF, using BCF alone provided the fastest reduction in herd prevalence and was the 
least costly alternative based on long-term cumulative costs of an annual test and cull 
program. 
There are only a limited number of studies evaluating the economic aspect of JD 
control strategies in beef cow-calf herds. Bennett et al. (2010) developed a deterministic 
cost-benefit model for the control of MAP in UK cow-calf herds under various control 
measures. Test and cull neither reduced the prevalence nor reduced the cost after 10 
years. However, the current study estimated that culling BCF-positives and obtaining 




less than 0.5% in five years. Eleven and 18 years were required to reach the same 
threshold using ELISA and EBCF, respectively. One of the major reasons for this 
difference is that within herd transmission was allowed in the Bennett et al. (2010) study 
while the current study assumed the sale of weaned calves and replacements exclusively 
obtained from low-risk herds. MAP transmission within the herd would hinder the 
effectiveness of a control program. 
Results from the current study suggest that although testing provides faster 
progress, limiting within herd transmission by sale of all weaned calves and purchasing 
only low-risk replacements alone can also reduce the prevalence. Bovine JD control 
programs have two key strategies for preventing spread among and within herds. Strict 
biosecurity measures and not allowing infected cattle to enter the farm are important for 
uninfected herds (Roussel, 2011) because purchasing replacements from herds without 
known low-risk status increases the likelihood of transmission (Sweeney, 1996; Kovich 
et al., 2006). The herd replacement rate and contact between cows and calves are 
important parameters when MAP transmission is modeled. Obtaining replacements with 
zero risk of MAP infection might not be feasible due to current test limitations. 
Therefore, the current study assumed that replacements were obtained from herds with 
less than 1% chance of being infected (Level 4 in older JD classification system). The 
model by Collins and Morgan (1992) in dairy herds was sensitive to cow-calf contacts 
because that is considered the primary method of transmission. Some studies suggest 
that testing is not necessary when herd hygiene can be improved (Dorshorst et al., 2006; 
Lu et al., 2008). However, those results were based on observations from dairy herds, 
and the Lu et al. (2008) study did not employ empirical data.  
Individual herd level costs may be important driving factors for an economic 
control program. Certain losses are recoverable by replacing test positives with low-risk 
cows. After the test based preferential culling, returns increased for a herd up to a certain 
threshold of true prevalence. Returns were lower for herds with true prevalence above 
these thresholds because, at a higher prevalence, the proportion of test positives is more 




the loss due to presence of infected stock remains along with the additional cost of 
obtaining low-risk replacements. Such factors are important because the estimates of the 
cumulative multi-year cost of disease control were most sensitive to culling rate and also 
to the price of culls and replacements. A herd with an atypical culling rate or in which 
the price of culls and replacements is not typical will not have similar economic returns 
as reported in the current study. Control rather than eradication may be the economically 
preferred option for the majority of commercial beef herds. Eradication is possible by 
maintaining a strong commitment to these strategies for a long period of time (Sykes, 
2000). Total herd depopulation with the removal of fecal materials has been 
recommended for small herds (Chiodini et al., 1984) although the feasibility is 
questionable. Selling of all calves, as assumed in this study, at least until the presence of 
MAP in the environment is no longer a risk might be a practical alternative. The high 
prevalence herds would otherwise progress slowly by annual testing due to the low 
sensitivity of available tests (Collins et al., 2006; Kudahl et al., 2007b; Kudahl et al., 
2008). A Pennsylvania dairy farm with 60% apparent prevalence did not reach zero even 
after 20 years of semi-annual herd fecal culture tests followed by culling positives 
(Benedictus et al., 2008). Eradication in beef herds could be faster than dairy herds but 
low sensitivity and imperfect specificity would still hinder control programs as the herd 
approaches near eradication. 
Specific and custumized control measures may be necessary for seedstock, or 
other specialized cow-calf herds, with an increased value of animals. Although test and 
cull decisions are not always profitable, control in seedstock herds might be important if 
restrictions were to be imposed on the sale of MAP-infected cattle (Kennedy and 
Allworth, 2000; Webb Ware et al., 2012). Factors that affect the decision to control JD 
on a herd include the discounts applied to sold animals, the duration of trading 
restrictions, and the adopted strategy (Webb Ware et al., 2012). Government or industry 





Results of Webb Ware et al. (2012) for a self-replacing beef herd in Australia 
suggested that eradication is only profitable in the longer term when discounts on the 
sale of stock from infected herds are high. Purchasing low-risk additions accelerates the 
progress towards eradication. Although only three testing scenarios were compared in 
the present study, the most sensitive test (BCF) was the best choice for faster reduction 
of prevalence and reduced cost. BCF also has the highest specificity and specificity is 
important because false positive results cause an additional loss in test-based culling. 
Therefore, more specific tests are mainly important if culling false positive cows needs 
to be avoided for economic reasons. Another economic factor is the overall cost of 
testing. Evaluation of the trade-off between the number of years needed to reduce the 
prevalence below a certain threshold and overall cost to reach that threshold is important 
for decision making. BCF was the best choice based on both criteria. 
Results from a dairy decision tree model by Dorshorst et al. (2006) suggested 
that a test-and-cull program is not always economically justifiable and the appropriate 
strategy depends on herd size, management types and initial MAP prevalence. Prior to 
this, Collins and Morgan (1991) developed a simulation model for JD control in dairy 
herds and concluded that test and cull was profitable when there was greater than a 6% 
prevalence. A modification of this model suggested that a test and cull program for JD 
was profitable at any prevalence over 1% (Collins and Morgan, 1992). The differences 
in these findings can be attributed to beef and dairy husbandry differences, particularly, 
the sale of  calves and none retained as home-raised replacements. Another difference is 
that the ELISA and EBCF evaluated in the current study were assumed to have a lower 
sensitivity compared to a test sensitivity of 50% assumed by Collins and Morgan (1991). 
Test costs were also assumed to be greater in the present study, although this would be 
expected due to changes in costs over time. 
Decision analysis models compare alternative courses while other factors are 
held constant. These comparisons should be limited to compare the relative impact of 
each course of action, but the estimated return may be affected by production parameters 




mortality, additional cost of treatment, and lower weaning weight of calves from MAP 
infected cows were considered in the current study. Other factors including indirect 
losses by reduced sales, loss of valuable genetic material due to premature culling, loss 
of export markets, lowered consumer confidence and the cost of litigation (Roussel, 
2011) might also be important. Similarly, there are other losses due to lower production 
and higher management costs (Ott et al., 1999; Dorshorst et al., 2006; Kudahl et al., 
2007a; Tiwari et al., 2008). Current estimates include additional veterinary expense per 
infected cows, but costs of morbidity and mortality due to diseases other than JD could 
be important additional indirect costs.  
The estimates presented at the individual cow-level are likely to remain the same 
for herds at the same level of prevalence even if they are larger or smaller, but some 
inherent differences due to herd size may exist. Some large herds may have a lower cost 
for testing, labor, veterinary fees, handling and shipping samples for analysis. Data to 
validate model results were not available and this is an important limitation of the study. 
Precise inputs and use of primary empirical data are strengths of this study, but the 
model was sensitive to a number of inputs. Therefore, accurate estimation of these 
factors is important for model validity. While these values were collected from a 
producer survey and empirical data, caution should be taken while estimating losses in 
herds with production parameters markedly different than those used in this model. Cow 
parity and age were assumed to have no effect on production parameters and costs in 
effort to simplify the model. However, variation was included by using stochastic inputs 
and this is one of the reasons for wide CRs for economic estimates.Presented results are 
expected to benefit producers and other beef industry stakeholders to inform decisions 
concerning economically justifiable herd control strategies. It is very costly to control or 
eliminate MAP once the infection is established in a herd. While test and cull might be 
beneficial, proactive measures to reduce infection in herds are important. Future studies 
should evaluate other potential control measures including vaccination (Stabel, 1998; 
Kalis et al., 2001; Juste, 2012) and management options to reduce infection in calves 




6. SUMMARY AND CONCLUSIONS 
 
6.1 Conclusions  
JD has been considered an economically important disease in cattle for over a 
century (Bang, 1906; Dunkin, 1936; Barkema et al., 2010). However, the majority of 
research has focused on dairy cattle (Benedictus et al., 1987; Collins and Morgan, 1991; 
Ott et al., 1999; Groenendaal and Wolf, 2008) and the disease has not been studied 
extensively in beef cattle operations. While there are some studies concerning the 
economic impact of JD in beef herds (Bennett et al., 2010; Webb Ware et al., 2012), this 
dissertation evaluates the specific economic consequences associated with JD in beef 
herds.  
Weaning weight loss was significant in cows positive to the tests for MAP 
organism or antibody. Higher MAP shedders produced lighter calves compared to 
moderate and low intensity shedders. Similar results were also observed in ELISA 
positive cows. Calves from cows with higher levels of serum antibodies against MAP 
had lower weaning weights. The monetary losses associated with lower weaning weight 
of calves from test-positive cows was significant. Average monetary losses from a calf 
from heavy fecal shedder cow was $157 per calf. The loss was $58 for a calf from strong 
ELISA positive cow. True infection status could not be determined, but a higher 
response to ELISA or higher MAP shedding intensity both are likely representative of 
infected cows in more advanced stages of JD. Classification of tested cows in two 
categories (i.e., positive and negative) is less discriminating relative to impacts on 
adjusted weaning weight, especially for ELISA, presumably due to false-positive 
outcomes. This study focused on the loss associated with weaning weight, but additional 
losses, including premature culling of affected cows and lowered weight of culled 
animals, also contribute to the cumulative economic effect at the herd level. 
The perceptions of beef producers and veterinarians concerning the burden of 
MAP infection in cow-calf herds and the measures for the control of new infections were 




producer groups. These producers were less likely to have an infected herd and more 
likely to enroll in a control program despite the fact that they purchased additions more 
frequently than other producer categories. However, it should be noted that the current 
study population consisted mainly (95%) of herds that were tested for MAP at least 
once. These producers presumably had better JD knowledge relative to the general cow-
calf producers. Testing purchased additions was not a popular practice nor was serum 
ELISA based culling. One of the most important routes of transmission among herds is 
the addition of subclinically infected animals. This is also supported by the results that 
closed herds had lower perceived prevalence, test positive percentage, and also a lower 
risk of having animals with clinical JD. Larger herds were more likely to have test-
positive cows, possibly due to a larger population being tested. A combination of tests 
and a 12-month testing interval was recommended by the majority of surveyed 
veterinarians. Educational activities regarding better management and control of JD 
should be directed at larger herds. 
This dissertation also compared the perceptions of producers and veterinarians on 
the economic aspects of MAP infection in cow-calf herds. There were mixed opinions 
and differences in the production metrics perceived by veterinarians and producers. One 
of the most significant economic concerns of commercial cow-calf producers was a 
lower weaning weight of calves from infected cows. The loss of valuable genetics when 
an MAP infected cow was culled was an important concern to seedstock producers. 
Similarly, all producers reported a significantly higher percentage of herd income lost 
due to the presence of MAP infected cattle. Based on the reported losses, an annual loss 
of $235 for each infected animal was estimated using information from the producer 
survey. The analogous estimate using information from veterinarians was $250. Such 
losses, when translated into a 100 cow herd with an assumed true prevalence of 7%, 
totaled $1,644 based on information provided by producers and $1,747 based on the 
information from veterinarians. This indicates that MAP infection in beef herds is 
associated with substantial economic losses. These estimates provide useful background 




concerning the estimated cost might motivate producers with MAP infected herds to 
initiate a JD control program. This could also encourage low prevalence herds to 
continue JD control efforts to improve market opportunities. 
The final study evaluated whether testing and culling MAP test-positive cows is 
economically justifiable to reduce herd-prevalence and to gain better productivity from 
replacement cows. A single test based culling was not profitable for a typical cow-calf 
herd at any level of prevalence. However, testing the herd annually effectively reduces 
the prevalence when the replacements are obtained from low-risk herds. BCF was the 
most sensitive and specific test, which caused the most rapid reduction in prevalence 
compared to ELISA, and ELISA confirmed by BCF. The cost to reduce the true 
prevalence from 10% to less than 0.5% was the lowest for BCF followed by ELISA and 
EBCF. BCF appears to be the most economic test for herds to reduce JD prevalence. 
The overall results presented in this dissertation suggest that commercial cow-
calf producers perceive a high loss due to lower weaning weight of calves born from 
MAP infected cows. Similar to the perception, observational data from cow-calf herds 
also demonstrated significantly lower weaning weight of calves from cows testing 
positive for MAP organisms or antibodies. For commercial cow-calf producers, 
minimizing the loss is the priority over reducing the prevalence per se. One way to 
minimize loss without aggressive investment in a control program is the implementation 
of management changes to reduce the spread of MAP within the herd. Selling all calves 
born in infected herds and obtaining replacements from low-risk herds to prevent further 
within-herd transmission results in a reduction in prevalence. For a quicker progress in 
reduction of prevalence, testing the entire herd by BCF is recommended. 
Concern about lower weaning weight is also important for seedstock producers. 
Previous reports suggest that compensatory growth of cattle born with lower weight 
during calfhood is less likely. While test based culling results in additional cost to the 
seedstock producers due to the higher value of genetically superior animals, lowering the 
herd prevalence is a priority for better marketability of their cattle. Therefore, even the 




all calves are sold and replacements are obtained from low-risk herds. One of the major 
challenges for seedstock producers is to obtain genetically desirable replacements from 
low-risk herds. There is a necessity of nationwide effort to establish more low-risk herds 
so that animals with desired superior genetics can be obtained as replacements. Breed 
associations can also track herds for specific pathogens including MAP and keep 
information about herds with lower risk of JD. 
Based on the perceptions and observed data, this dissertation concludes that herd 
level losses decrease with lowered prevalence. In a herd going through a control 
program, the number of better producing uninfected stocks increases after each culling 
and replacement. While there is usually additional cost associated with any control 
program, there is a potential of recovery of this cost with increased returns from 
increasing number of uninfected stocks as the herd progresses towards MAP eradication. 
For the herds going through a control program, total cost to reduce the true prevalence 
from 10% to less than 5% was lowest for BCF, followed by ELISA, and ELISA 
confirmed by BCF. Therefore, BCF is the recommended test for herds to reduce JD 
prevalence although it was the least frequently recommended test by the veterinarians 
for herds starting a control program to reduce MAP prevalence by test-based culling.  
 
6.2 Proposed future studies 
A comprehensive study using nationwide data on production metrics in beef 
herds would be an important step towards generating more accurate estimates of losses 
associated with JD in beef herds. Proper preparation and an effective data collection 
mechanism would provide more informative results. While several categories of losses 
were perceived to be important, producers probably did not formally evaluate farm 
records when providing questionnaire responses. Longitudinal data from different types 
of beef production units would be valuable to make more precise estimates. Additional 
surveys of producers including those who have not been enrolled in a control program or 
have tested herds would be beneficial to compare perceptions among all production 




effort to improve the validity. The predictive ability of multi-year testing would be 
improved by incorporating data collected from producers over several years. Validation 
of decision tree and multi-year test-based culling will also be possible after the collection 
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Apparent Prevalence (AP) = TP (Se + Sp – 1) +1– Sp, where Se = sensitivity and Sp = specificity. 
True positive (TP) = Se. True prevalence 
False positive (FP) = AP – TP  
False Negative (FN) = True Prevalence –TP 
True Negative (TN) = 1-True Prevalence – FP 
* Testing herds obtain replacements from low-risk herds (expensive) compared to not-testing herds 
who have no preference to low-risk herds  








This figure represents the node values associated probabilities in the decision tree. For example, a 
producer who decided to not test the herd (A) has cows with 10% probability (B) of being infected 
based on the assumption of 10% herd prevalence. Having an infected cow adds $27.5 (C) 
additional veterinary expense per year. At an annual culling rate of 12.55% (D), the probability of 
retaining an infected cow is 87.45% (E). Probability that an infected cow calves is 73.8% (F). A 
calf given by an infected cow provides a return of $562 (G). At the true prevalence of 10%, the 
probability of a cow in the herd being not infected is 90% (H). If an uninfected cow remains in the 
herd, it has a calving probabity of 92.73% (I), and thus provides a return of $681.95 (J) when it 
calves. Each cull is replaced to maintain a constant herd size and that cost was $257.87. 






This figure shows all the branches from ELISA test decision expanded, while other options are 
collapsed. Starting from the base of the tree, the first decision of the producer is either to test or no 
test (A). For this illustration, ELISA is taken as the choice (B). The cost of ELISA test is $14.60 
(C). The probabilities of a tested cow being true positive (TP), false positive (FP), false negative 
(FN) or true negative (TN) were estimated (D). The TP+FN make up the total infected cows or 
10% in this example. An infected cow results an additional annual veterinary cost of $27.50 (E). 
Culling probabilities and calving probabilities were estimated as in the previous page. Apparent 
Prevalence (AP) = TP (Se + Sp – 1) +1– Sp, where Se = sensitivity and Sp = specificity. True 
positive (TP) = Se. True prevalence. False positive (FP) = AP – TP. False Negative (FN) = True 






The return at each node is estimated based on the values and probabilities associated with the child 
branches. The software estimates these values by “averaging out and folding back.” The calving 
probability at the topmost end node is 73.8% (A) and the probability of not calving (open) is thus 
100%-73.8% 26.2%. The return from a calf given by that cow is $589.68 (B). When adjusted for 
the additional veterinary expense for infected cow ($27.5, C) and test cost (D, $15.54), The net 
return (E) can be calculated as: B-C-D= $589.68-$27.50-$15.54 = $546.65=E. Associated returns 
and probabilities when multiplied and added to get probability weighted average estimate the 
average return at that chance node as: (546.65*.738)-(26.2*0.4304) = $392.13 (F). Similarly, 
probability weighted average of F and G result in the value H = (14.43%)*(-649.18, 
G)+(87.57%)*($392.13, F)=$241.89. Further estimation in the same manner provides the value at 





Annual return from a cow at specific permutation of producer’s decision to test or not test, 
cow’s infection status, test status and reproductive performance  


































































Calved $681.95  








Simplified version of decision tree with all child branches collapsed. The expected annual returns 
are negative for all test options with –$212, – $47 and –$435 for ELISA, fecal culture (BCF) and 
ELISA positives confirmed by BCF (EBCF), respectively. The decision among the test choices is 
fecal culture with the best return, or the lowest cost of $47 the given true prevalence of 10%.  
However, in the overall tree, the no-test option has a return of $501, and is the most economic 
decision in as shown in Figure 6 of the dissertation (reproduced below). 
 
Copy of Figure 6: Average cow level return at different levels of prevalence based on tests 
for Mycobacterium avium subspecies paratuberculosis in beef cow-calf herds. Estimated 
based on the following options: no-test (dotted line), ELISA (solid line), bacterial culture of 
feces (long dash), and ELISA screening followed by bacterial culture of feces confirmation 
(short dash).  
 
